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 Aquaculture supplies the world market with over 50% of food fish and is an 
economically important industry, however limited disease management strategies often lead to 
significant economic losses and/or poor-quality product.  Historically, antibiotics were used 
prophylactically and as a treatment in disease outbreaks caused by bacterial infections, however, 
due to antibiotic resistance among pathogens alternative methods for disease control are required 
and strong vaccination programs are essential.  Vibrogen 2, is considered a successful vaccine 
available for use in aquaculture, however the reasons for this success are poorly understood.  
Furthermore, while fish appear to have immunological machinery and signaling molecules 
similar to those found in mammals, evidence suggests fish may use these immune mechanisms 
differently.  In this study, the early immune response elicited by Vibrogen 2 vaccination in 
rainbow trout head kidney and RTS11 cells was examined through investigation of mRNA 
expression of two pro-inflammatory cytokines; IL-1β and IFNγ, as well as the mRNA expression 
of MH class I associated TAP1 and MH class II associate S25-7, to understand the efficacy of 
the bacterin, as well as, the innate/adaptive immunity interface in teleosts.  In RTS11 cells 
Vibrogen 2 up-regulated IL-1β, S25-7 and TAP1 but not IFNγ in the first 24h post-stimulation 
and in rainbow trout head kidney IL-1β, IFNγ and TAP1 but not S25-7 was up-regulated in the 
first 24h after vaccination.  Moreover, at 24h S25-7 expression was trending down in head 
kidney.  The results suggest Vibrogen 2 is initiating antibody production in rainbow trout via the 
pro-inflammatory pathway while the MH class I pathway is also activated.  Further, it is possible 
that 14-1 or INVX rather than S25-7 is involved in MH class II presentation in rainbow trout 
head kidney.  It appears both MH class I and MH class II may be involved in the development of 
long term immunity in fish and thus, both pathways should be considered when developing 
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1.1  Nutritional Value of Fish 
Fish is an important food source that provides high quality protein that contains all of the 
essential amino acids for a healthy diet (Food and Agriculture Organization of the United 
Nations, 2016; Health Canada, 2011).  In 2013, fish was a key source of protein for over 3.1 
billion people, providing them with approximately 20 percent of their average per capita animal 
protein (Food and Agriculture Organization of the United Nations, 2016).  Overall, this per 
capita animal protein value accounted for 17 percent of the global animal protein intake and 6.7 
percent of total protein intake in 2013 (Food and Agriculture Organization of the United Nations, 
2016).  Additionally, fish is an excellent source of essential fatty acids such as long chain omega-
3-fatty acids and a good source of vitamins, such as vitamins, D, A and B, as well as minerals, 
such as, calcium, iodine, zinc, iron and selenium (Food and Agriculture Organization of the 
United Nations, 2016; Health Canada, 2011).  Species identified by Health Canada, (2011) to be 
very high in omega-3 fats include rainbow trout, salmon, char, herring, mackerel, and sardines. 
Due to the health benefits of fish, particularly those with high levels of unsaturated fat, which 
plays a role in reducing the risk of cardiovascular disease and supports fetal and infant neural 
development, Health Canada, (2011) recommends at least two servings of fish each week (Food 
and Agriculture Organization of the United Nations, 2016).  Furthermore, fish can be valuable in 
correcting unbalanced diets and reducing saturated fat intake to help manage obesity and weight 
gain (Food and Agriculture Organization of the United Nations, 2016).  In the past, capture 
fisheries supplied the global market with enough food fish to meet consumer demands (Food and 
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Agriculture Organization of the United Nations, 2016). However, today over 50 percent of food 
fish is being produced by the aquaculture industry (Food and Agriculture Organization of the 
United Nations, 2016). 
1.2  World Aquaculture  
Hundreds of millions of people worldwide rely on fisheries and aquaculture not only for food 
and nutrition but also as a livelihood (Food and Agriculture Organization of the United Nations, 
2016).  However, while capture fishery production has remained relatively static since the late 
1980s, aquaculture production has continued to grow, and now supplies half of all food fish to 
the global market (Food and Agriculture Organization of the United Nations, 2016).  This 
reflects substantial growth of aquaculture considering the industry supplied the global market 
with only seven percent of food fish in 1974, and 2014 marked a record high world per capita 
fish supply, which reached an impressive 20kg per year (Food and Agriculture Organization of 
the United Nations, 2016).  This is coupled with a significant growth in fish consumption that 
reflects an enhanced diet for people around the world, not only providing important nutrition but 
also diversification (Food and Agriculture Organization of the United Nations, 2016).  
The top ten countries involved in exportation of fish and fishery products in 2014, and the 
value in US$ millions each country exported are listed in Table 1-1, while the top ten countries 
involved in importation of fish and fishery products in 2014, and the value in US$ millions each 
country imported, are listed in Table 1-2.  In 2014, the combined value of exported  fish and 
fishery products from the top ten exporters in US$ millions was 77 801, while all remaining 
countries involved in aquaculture product export accounted for 70 346 US$ millions (Food and 
Agriculture Organization of the United Nations, 2016).  The 2014 combined value of 
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Table 1-1: Top Ten Countries in 2014 Exporting Fish and Fishery Production 
Rank Country Value 
US$ Millions 
1 China 20 980 
2 Norway 10 803 
3 Viet Nam 8 029 
4 Thailand 6 565 
5 United States of America 6 144 
6 Chile 5 854 
7 India 5 604 
8 Denmark 4 765 
9 Netherlands 4 555 
10 Canada 4 503 
(Food and Agriculture Organization of the United Nations, 2016) 
Table 1-2: Top Ten Countries in 2014 Importing Fish and Fishery Production 
Rank Country Value 
US$ Millions 
1 United States of America 20 317 
2 Japan 14844 
3 China 8501 
4 Spain 7051 
5 France 6670 
6 Germany 6205 
7 Italy 6166 
8 Sweden 4 783 
9 United Kingdom 4 638 
10 Republic of Korea 4 271 
(Food and Agriculture Organization of the United Nations, 2016) 
imported fish and fishery products from the top ten importers in US$ millions was 83 447, while 
all remaining countries that import fish and fishery products accounted for only 57 169 US$ 
millions (Food and Agriculture Organization of the United Nations, 2016). Moreover, fish has 
become a leading export for developing countries and in 2014 was valued at over 35 billion US 
dollars compared to coffee export which was valued at only about 15 billion US dollars in 2014 
(Food and Agriculture Organization of the United Nations, 2016).  
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At the top of the list of species being traded on the world market is salmon, trout and 
smelt, which account for 16.6 percent of share by value and 7.2 percent share by live weight in 
world trade for 2013 (Food and Agriculture Organization of the United Nations, 2016).  In fact, 
salmon, along with shrimp, bivalves, tilapia, carp and catfish, is a key species involved in driving 
global demand and consumption due to the shift in supply from primarily wild-caught to farmed 
product (Food and Agriculture Organization of the United Nations, 2016).  Additionally, the 
increased production of salmon, trout and freshwater fishes, has led to a significant growth in 
yearly per capita consumption of freshwater and diadromous species, which reached 7.3kg in 
2013, up from only 1.5kg in 1961 (Food and Agriculture Organization of the United Nations, 
2016).  Over the next ten years, it is anticipated that the production of salmon, particularly 
Atlantic salmon, and trout, will continue to grow, and new markets for processed products as 
well as a higher demand for salmon over sashimi tuna, will be valuable support for this growth 
(Food and Agriculture Organization of the United Nations, 2016).  By 2025, it is expected that 
world fish consumption will increase by 31 million tonnes, reaching 178 million tonnes (Food 
and Agriculture Organization of the United Nations, 2016).  Figure 1 summarizes the predicted 
2025 increase in fish consumption by continent, while Figure 2, illustrates the predicted 2025 
relative production of capture fisheries and aquaculture, compared to the predicted relative 
consumption of fish supplied by capture fisheries and aquaculture.   
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Figure 1-1: Predicted additional consumption of fish in 2025 by continent. (Food and 
Agriculture Organization of the United Nations, 2016).  
 
Figure 1-2: Predicted relative global fish production and consumption by aquaculture and 
capture fisheries for 2025. (Adapted from Food and Agriculture Organization of the United 

















Together these figures illustrate the need to support the growth of the aquaculture industry to 
meet the food needs of the future.  Canadian aquaculture has played an important role in the 
rapid growth of the aquaculture industry and has the potential to be a leading supplier of food 
fish for the future. 
1.2.1 Canadian Aquaculture  
The Canadian aquaculture industry utilizes the oceans and freshwater lakes and rivers, as 
well as, land-based ponds and tanks to produce farmed products including about 45 different 
species of finfish, shellfish and marine algae (Fisheries and Oceans Canada, 2014).  All ten 
Canadian provinces, as well as the Yukon Territory, are involved in aquaculture; however, the 
2015 value added report by Fisheries and Oceans Canada (2017), lists only seven provinces: 
Newfoundland, Prince Edward Island, Nova Scotia, New Brunswick, Quebec, Ontario and 
British Columbia (Fisheries and Oceans Canada, 2014; Food and Agriculture Organization of the 
United Nations, 2013).  These seven provinces are making an important contribution to the 
Canadian economy, and in 2015, not only contributed $826.6 million to the gross value, but also 
supported employees and their families paying out a total of $112.2 million in salaries and wages 
(Fisheries and Oceans Canada, 2017).  In 2013, the Canadian aquaculture industry represented 
about a third of the country’s total fisheries value, produced about 20 percent of Canada’s total 
seafood, and was valued at $962 million (Fisheries and Oceans Canada, 2013).  This marks an 
increase of 63 percent over a ten year span as the industry was valued at only $591 million in 
2003, and overall a four-fold increase since the early 1990s (Fisheries and Oceans Canada, 
2013).   
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On the global market Canada is number ten on the 2014 export list (Table 1-1).  Notably, the 
United States of America (USA) is Canada’s biggest salmon export market and the majority of 
rainbow trout produced in Canada are exported to the USA as well (Fisheries and Oceans 
Canada, 2015a, 2015b).  In terms of the Canadian economy, the gross value of finfish production 
by the Canadian aquaculture industry in 2015 was $877.9 million (Fisheries and Oceans Canada, 
2017).  Total production value reflects production of salmon, including Atlantic, Chinook and 
Coho, trout, primarily rainbow and brook, as well as, steelhead, which are rainbow trout that 
spend a portion of their life in saltwater, and a small number of other species currently farmed in 
Canada (Fisheries and Oceans Canada, 2015a, 2017).  Overall, salmon farming is economically 
important to Canada as it is the third largest seafood export by value, and plays a key role in the 
economy of coastal and rural communities on both the east and west coast (Fisheries and Oceans 
Canada, 2015a).  
Canada is a top salmonid producing country and in 2013 was the number four producer of 
salmon species (Fisheries and Oceans Canada, 2013, 2015a).  Indeed, the top Canadian 
aquaculture export is Atlantic salmon, the majority of salmon produced in Canada is farmed in 
British Columbia, and salmon is the top agriculture export from this province (Fisheries and 
Oceans Canada, 2015a).  However, while salmon is the top saltwater fish farmed in Canada, 
rainbow trout and brook trout are the most commonly farmed freshwater salmonids (Fisheries 
and Oceans Canada, 2015b).  Trout are produced in all ten Canadian provinces: Alberta, British 
Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, 
Quebec, Prince Edward Island, and Saskatchewan (Fisheries and Oceans Canada, 2015b).  
Markedly, Ontario is the largest producer of trout species in Canada with the majority of grow-
out sites situated in the Northern part of the province, primarily in Georgian Bay and the North 
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Channel of Lake Huron around Manitoulin Island (Fisheries and Oceans Canada, 2015b).  
Additionally, Quebec is the second largest producer of trout in Canada, and notably, rainbow 
trout farming is an important industry in Saskatchewan (Fisheries and Oceans Canada, 2015b).  
Across Canada aquaculture is an active industry that, over the past two decades, has experienced  
rapid growth (Fisheries and Oceans Canada, 2013).  Considering Canada has the longest 
coastline in the world and wise use of our water resources alone, will allow growth of the 
Canadian aquaculture industry, especially in coastal provinces, the nation is poised to play an 
integral part in meeting the food needs of the future (Natural Resources Canada, 2015).  
However, water resources are not the only consideration in the development of sustainable 
aquaculture.   
1.2.2 World Population Growth and the Importance of Sustainable 
Aquaculture 
Climate change, economic and financial uncertainty and an ever-increasing competition for 
natural resources, combined with the expectation that the world population will continue to 
grow, and by 2050 is predicted to reach over 9.5 billion, presents one of the greatest challenges 
faced today: How will future generations be fed (Food and Agriculture Organization of the 
United Nations, 2016)?  Currently, aquaculture is the fastest-growing food production sector and 
recent recognition that the oceans, inland lakes and waterways found all over the world hold 
great potential to make a significant contribution to food security and nutrition, not just today but 
in the future, is encouraging (Food and Agriculture Organization of the United Nations, 2016).  
However, there are hurdles to overcome, such as, control of disease before sustainability of the 




1.3 Disease in Finfish Aquaculture 
Disease occurs in both saltwater and freshwater production and can affect fish at any stage of 
development (Ingerslev, Hyldig, Przybylska, Frosch, & Nielsen, 2012).  Infectious agents 
causing disease in finfish aquaculture include viruses, parasites, bacteria and fungi (Dhar, 
Manna, & Thomas Allnutt, 2014; Ingerslev et al., 2012).  Of these the most prevalent disease 
causing agent is bacteria which accounts for 54.9 percent of disease in finfish production, while 
viruses account for 22.6 percent, parasites account for 19.4 percent and fungi account for 3.1 
percent of disease in farmed fish (Dhar et al., 2014).  Certainly, disease can result in mortality 
however, even when fish survive, fillet quality is reduced by the presence of parasites, and both 
viral and bacterial disease can cause bleeding and irreversible damage in the musculature 
(Ingerslev et al., 2012; Lafferty et al., 2014).  Thus, disease frequently results in significant 
losses in aquaculture and it has been reported that over the past 20 years disease outbreaks have 
cost the industry tens of billions of dollars (Food and Agriculture Organization of the United 
Nations, 2016).  Despite lower prevalence of viral disease, some have argued that viral diseases 
are more difficult to control due to lack of treatment options, such as, anti-viral agents (Dhar et 
al., 2014).  However, continued use of antibiotics, the main treatment for bacterial infection is no 
longer a viable option, due to antibiotic resistance among pathogens (Austin & Austin, 2016a; 
Haenen et al., 2014; Ingerslev et al., 2012; Magnadottir, 2010; Pridgeon & Klesius, 2012; 
Tuševljak et al., 2013).  According to a survey conducted by Tuševljak et al., (2013) nine 
antimicrobial drug classes: aminoglycosides, tetracyclines, macrolides, nitrofurans, penicillins, 
phenicols, potentiated sulphonamides, quinolones and sulphonamides, are in use for treatment of 
diseases in finfish such as salmon and trout.  Of these, resistance to four treatments, 
tetracyclines, potentiated sulphonamides, penicillins and phenicols, was frequently reported for 
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several pathogens affecting a variety of farmed species (Tuševljak et al., 2013).  This study also 
surveyed the antimicrobial resistance for six aquatic pathogens and reported that the two most 
frequently resistant bacterial strains were Aeromonas spp. and Vibrio spp. (Tuševljak et al., 
2013).  In fact, for five of the nine antimicrobials 20 percent or more of respondents indicated 
frequent observation of resistance by Aeromonas spp. and for three of the nine drugs 20 percent 
or more of respondents indicated frequent observation of resistance by Vibrio spp. (Tuševljak et 
al., 2013).  The resistance of Vibrio spp. to antimicrobials, together with the impact vibriosis, the 
disease caused by Vibrio spp., has on survival and product quality is alarming (Food and 
Agriculture Organization of the United Nations, 2016; Ingerslev et al., 2012; Lafferty et al., 
2014; Le Roux et al., 2015).  It is evident that in the years ahead bacterial diseases in aquaculture 
will likely become increasingly problematic given  the growing number of antibiotic resistance 
strains (Food and Agriculture Organization of the United Nations, 2016; Tuševljak et al., 2013).   
This, along with the sizeable economic impact disease has on the aquaculture industry, highlights 
the need for appropriate biosecurity and health management practices to support resilience within 
the industry and strong vaccination programs will be at the heart of sustainable aquaculture 
(Food and Agriculture Organization of the United Nations, 2016). 
1.3.1 Vibrio anguillarum and Vibrio ordalii: Causative Agents of Salmonid 
Vibriosis 
Two Vibrio spp.; Vibrio anguillarum, and Vibrio ordalii, have a long history of causing 
vibriosis, the most serious and significant disease in marine fish, and are responsible for severe 
economic losses in aquaculture (Avci, Birincio Lu, & Çagirgan, 2012; Busschaert et al., 2015; 
Frans et al., 2011; Poblete-Morales et al., 2013; Ruiz, Poblete-Morales, Irgang, Toranzo, & 
Avendaño-Herrera, 2016; Schiewe, Trust, & Crosa, 1981; Steinum et al., 2016).  In fact, disease 
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in marine fish caused by Vibrio spp., has been reported as far back as the early eighteenth 
century, and while Bacillus anguillarum was first linked to diseased eels in 1817, in 1909 V. 
anguillarum was identified as the causative agent of the disease in eels known as Red Pest 
(Actis, Tolmasky, & Crosa, 2011; Schiewe et al., 1981).  In 1972 a second Vibrio spp. strain was 
identified as the causative agent of atypical vibriosis and was named V. anguillarum biotype II, 
however, in 1981 Schiewe et al., provided data supporting the separation of the two strains and 
V. anguillarum biotype II was renamed V. ordalii (Ruiz et al., 2016; Schiewe et al., 1981; 
Steinum et al., 2016).  Over the years nomenclature used to identify these organisms was further 
confused as V. anguillarum was also named Listonella anguillarum for a time, however, today V. 
anguillarum is the accepted and most commonly used terminology (Austin & Austin, 2016b; 
Avci et al., 2012; Frans et al., 2011; Silva-Rubio et al., 2008).  
There are 23 different V. anguillarum serotypes and two are responsible for the majority of 
vibriosis outbreaks in fish: O1 and O2, while a third, O3, also plays a small role in disease 
(Busschaert et al., 2015; Frans et al., 2011; Steinum et al., 2016).  The remaining serotypes are 
mainly non-pathogenic organisms found in environmental samples such as sediment, plankton 
and sea water (Busschaert et al., 2015; Frans et al., 2011; Poblete-Morales et al., 2013).  Vibrio 
anguillarum serotypes O1 and O2 are responsible for the majority of vibriosis disease in 
salmonid species and Larsen, Pedersen, & Dalsgaard, (1994), identified 302 of 322 strains 
isolated from salmonids as type O1 or O2.  In fact, of the 322 strains isolated 70.2 percent 
belonged to the O1 serotype while 20.2 percent belonged to the O2 serovar (Larsen et al., 1994).  
Vibrio anguillarum, which can infect several different fish species including Atlantic salmon, 
Pacific salmon and rainbow trout, is a Gram-negative, 0.5 × 1.5μm rod, with a shape resembling 
a comma (Austin & Austin, 2016b; Frans et al., 2011; Rodkhum, Hirono, Crosa, & Aoki, 2005).  
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This organism is motile and has a polar flagella that can rotate up to 1 700 rotations per second 
(rps) allowing the bacterium to swim up to 60µm/s (Mccarter, 2001).  Additionally, V. 
anguillarum, is a non-spore forming facultative anaerobe that is halophilic, meaning it grows 
well in high salt environments, and grows in a temperature range of 15-37oC (Austin & Austin, 
2016b; Frans et al., 2011).  Furthermore, rapid growth of this bacterium has been observed 
between 25-30oC (Actis et al., 2011; Frans et al., 2011).  Vibrio ordalii, which has been isolated 
from coho, chum and spring Chinook salmon, is a Gram-negative, 2.5–3.0 × 1.0μm, curved rod 
that like V. anguillarum is motile by a polar flagella (Actis et al., 2011; Austin & Austin, 2016b). 
The temperature range for growth of V. ordalii is more limited than that of V. anguillarum and is 
15-22oC (Austin & Austin, 2016b).  Both V. anguillarum and V. ordalii degrade gelatin, 
however, haemolysins and proteases have been identified in V. anguillarum but not V. ordalii 
(Austin & Austin, 2016b; Rodkhum et al., 2005).  Additionally, metalloproteases, dermatotoxin, 
hemagglutinin and cytotoxin, are secreted exotoxins that have been associated with V. 
anguillarum strains and are correlated with disease pathogenesis and some strains carry a 65 kilo 
base (kb) pJM1 or pJM1-like plasmid allowing these strains to synthesis and transport the 
virulence factor, siderophore anguibactin (Naka et al., 2011; Rodkhum et al., 2005).  In 
comparison, little is known about the virulence factors associated with V. ordalii infection 
however, recent work by Ruiz, Balado, et al., (2016), has demonstrated that this organism has 
two different iron acquisition systems; one involves synthesis of siderophore, and a second 
involves direct binding of haeme, and this iron uptake is related to pathogenicity (Actis et al., 
2011).  There is some uncertainty regarding the mode of infection of V. anguillarum and V. 
ordalii, however it is clear that infection is a result of bacterial colonization and tissue 
penetration and proposed sites of entry include the skin, fins, anus, intestine and rectum (Austin 
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& Austin, 2016b; Kanno & Nakai Muroga, 1990; Ruiz et al., 2016).  Additionally, the 
temperature and quality of the water as well stress and strain virulence play a role in infection 
and disease outbreak (Actis et al., 2011).   
1.4 Vibriosis 
Vibriosis outbreaks have been reported in nearly 50 different fish species in multiple 
countries on both the Atlantic and Pacific coasts and have occurred in both fresh and saltwater 
fish (Actis et al., 2011; Frans et al., 2011; Kanno & Nakai Muroga, 1990). Indeed vibriosis, 
caused by Vibrio spp., has been recognized as one of the most widespread fish diseases and is 
among the most important diseases in aquaculture (Actis et al., 2011; Busschaert et al., 2015).  
Vibriosis, caused by V. anguillarum is characterized by a haemorrhagic septicemia and red spots 
on the ventral and lateral tissues (Actis et al., 2011; Busschaert et al., 2015; Frans et al., 2011; 
Munn, 1977; Poblete-Morales et al., 2013).  Infected fish lose weight, become lethargic, develop 
skin discolouration and dark swollen necrotic skin lesions that abscess and bleed (Actis et al., 
2011; Austin & Austin, 2016b; Frans et al., 2011; Li, Mou, & Nelson, 2013; Munn, 1977).  
Bloody patches, or erythema, is observed around the fins and vent as well as in the mouth and 
haemorrhaging occurs in the gills, gut and muscle (Austin & Austin, 2016b; Ransom, Lannan, 
Rohovec, & Fryer, 1984).  Lesions of the eye may also develop first resulting in opacity 
followed by the development of ulcers and finally abnormal protrusion or bulging of the eye 
(Actis et al., 2011; Frans et al., 2011).  Additionally, distention of the intestines may be observed 
due to accumulation of a clear viscous liquid and high bacterial cell counts are obtained from 
blood, haematopoietic tissues, such as kidney, and from the spleen, liver and gut  as well as the 
heart and connective tissues (Actis et al., 2011; Austin & Austin, 2016b; Frans et al., 2011; 
Ransom et al., 1984).  Notably, in acute disease outbreaks infection spreads rapidly and 
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mortalities occur in fish infected but without any clinical signs of disease (Actis et al., 2011; 
Frans et al., 2011).  Atypical vibriosis, caused by V. ordalii, may also present with haemorrhagic 
septicemia however the development of bacteremia generally occurs later in disease progression 
than it does with V. anguillarum infection (Austin & Austin, 2016b; Ransom et al., 1984).  
Instead, V. ordalii tends to localize in muscle and skin tissues aggregating and forming micro-
colonies in the heart, skeletal muscles, loose connective tissues as well as gill tissue, gut and 
pyloric caeca  (Actis et al., 2011; Austin & Austin, 2016b; Ransom et al., 1984).  Due to this 
localization and aggregation bacteria are not uniformly distributed in tissues in V. ordalii 
infection as they are with V. anguillarum infection (Ransom et al., 1984).  In some instances 
bacterial aggregates may completely replace host tissue however, necrosis of the area may or 
may not be present (Actis et al., 2011; Ransom et al., 1984).  Additionally, Ransom et al., (1984), 
did not observe V. ordalii in the kidney of infected fish and only found occasional bacterial 
colonies in the liver and spleen (Actis et al., 2011).  Vibriosis outbreaks generally occur in salt or 
brackish water during late summer and are most problematic in shallow water (Actis et al., 
2011).  In general, V. anguillarum is the primary pathogen encountered by salmonids such as, 
Atlantic salmon, Pacific salmon and rainbow trout during their first year at sea (Jansson & 
Vennerstrom, 2014).  However, V. ordalii, has been responsible for recent disease outbreaks in 
aquaculture of all three species in Chile (Actis et al., 2011; Ruiz et al., 2015, 2016; Silva-Rubio 
et al., 2008).  In addition to V. anguillarum and V. ordalii, several other Vibrio spp. are 
responsible for vibriosis outbreaks in fish and shellfish including, Aliivibrio salmonicida 
(formerly Vibrio salmonicida), the causative agent of cold water vibriosis in Atlantic salmon, 
rainbow trout and cod and Vibrio vulnificus biotype II, the causative agent of vibriosis in 
cultured eel (Actis et al., 2011; Haenen et al., 2014).  Vibriosis has high morbidity and a 
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mortality rate that can be as high as 100%, thus, antimicrobials are often used as a therapeutic 
treatment  however, fish in poor health often stop eating reducing antimicrobial uptake and 
recovered fish produce lower quality fillets due to histopathogenesis (Austin & Austin, 2016b; 
Busschaert et al., 2015; Hickey & Lee, 2017; Li et al., 2013; Munn, 1977; Poblete-Morales et al., 
2013). 
1.4.1  Vibriosis in Canada 
While Vibrio spp. outbreaks have been reported all over the world since the early 1900s and 
throughout the early 1900s were problematic in the USA, the first cases of vibriosis in Canada 
were not reported until in the late 1960s (Evelyn, 1971).  In 1968 on July 22nd vibriosis was first 
observed in Canada in a stock of under-yearling chum salmon housed at the Nanaimo Research 
Station and two days later disease was observed in a second stock of fish; two year old sockeye 
salmon (Evelyn, 1971).  At a second site, the Pacific Environment Institute, Fisheries Research 
Board of Canada, West Vancouver an outbreak of vibriosis occurred in yearling pink and 
Chinook salmon in August through September of that same year (Evelyn, 1971).  The 
approximated water temperature at both locations at the time of disease outbreak was at the 
annual maxima expected; 15oC at Nanaimo Research Station and 12oC at the Pacific 
Environment Institute and confirmatory testing identified V. anguillarum as the causative agent 
at both sites (Evelyn, 1971).  Throughout the early 1970s vibriosis outbreaks among cultured 
salmonids on the Canadian West Coast remained problematic and in 1976 V. ordalii was isolated 
for the first time from nearby cultured Pacific salmon on the USA west coast in Puget Sound, 
Washington  (Evelyn, 1984; Harrell, Novotny, Schiewe, & Hodgins, 1976).  Indeed, in the early 
1970s vibriosis outbreaks were occurring around the world, but it was the constraint of disease 
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outbreaks faced by culturists on the West Coast of North America that spurred the development 
of preventative vibriosis vaccines  (Evelyn, 1984).   
1.4.2  Prevention and Treatment of Vibriosis 
Currently, there are several practices implemented by fish farmers to control bacterial disease 
in aquaculture including: adequate husbandry and management practices such as preventing 
movement of infected stock, use of genetically resistant fish strains, providing suitable diets and 
appropriate use of dietary supplements; water treatments including use of disinfectants such as 
benzalkonium chloride, chlorine and formalin and use of antibiotics such as Florfenicol, 
Flumequine and potentiated sulphonamides when fish refuse feed as well as; use of probiotics, 
prebiotics, antimicrobial compounds and/or vaccines (Austin & Austin, 2016a).   The use of 
antibiotics such as Florfenicol, to control vibriosis has met with some success however, 
treatment is generally administered as a food additive thus, it is essential that antibiotics be 
provided early in the disease cycle as loss of appetite ensues as the disease progresses (Austin & 
Austin, 2016b).  While the use of antibiotics has historically been at the heart of strong disease 
management practice in aquaculture, the use of antibiotics as a preventative measure is now 
discouraged because, as described above, antibiotic over use leads to resistant pathogens leaving 
antibiotics ineffective as a treatment (Austin & Austin, 2016a; Haenen et al., 2014; Ingerslev et 
al., 2012; Magnadottir, 2010; Pridgeon & Klesius, 2012; Tuševljak et al., 2013).  Additionally, in 
a survey of aquaculture professionals asked to identify observed resistance associated with six 
different aquatic pathogens, Vibrio spp. were the second most frequently reported pathogen 
associated with antibiotic resistance (Austin & Austin, 2016b; Tuševljak et al., 2013).  
Furthermore, the primary causative agent of finfish vibriosis, V. anguillarum, is a pathogen with 
high potential risk of antibiotic resistance as plasmids or R factors associated with some strains 
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confer resistance to multiple antibiotics including chloramphenicol, streptomycin, sulphonamides 
and tetracycline (Austin & Austin, 2016b).  Therefore, appropriate alternate preventative 
measures are essential for control of vibriosis in aquaculture.  While probiotics such as Kocuria 
SM1 have been shown to be effective in preventing vibriosis in rainbow trout, vaccines may be a 
more effective means of disease control and vaccine development has garnered much attention 
(Austin & Austin, 2016a, 2016b; Dixon, 2012; Pridgeon & Klesius, 2012; Sharifuzzaman & 
Austin, 2010).   
1.5 Aquatic Vaccine Development and Methodologies 
The first attempt to develop a vaccine to a bacterial fish pathogen was made by Duff, in 1942 
and in the 75 years since, vaccines to only about half of existing bacterial fish pathogens have 
been developed (Austin & Austin, 2016a).  Certainly research has moved forward investigating  
potential vaccine components such as cell lysates, inactivated whole cells, live-attenuated and 
DNA subunit vaccines, as well as, purified sub-cellular components such as lipopolysaccharides 
(LPS) and inactivated soluble cell extracts such as toxins, however, it has been difficult to 
identify a specific preparation that out performs the rest in terms of long term immunity (Austin 
& Austin, 2016a; Pridgeon & Klesius, 2012).  A variety of inactivation methods for whole cell 
preparations have also been considered including heat, pressure and electric current, as well as, 
chemicals (Austin & Austin, 2016a).  Researchers have used 3 percent (v/v) chloroform, 0.3-0.5 
percent (v/v) formalin and 0.5-3.0 percent phenol in whole cell preparations (Austin & Austin, 
2016a).  Commercially formalin inactivation is favoured given successful results in vaccine trials 
against several fish pathogens including V. anguillarum and V. ordalii (Austin & Austin, 2016a).  
Even though formalin inactivated whole cell preparations have met with some success, data 
comparing inactivated whole cell vaccines prepared with differently inactivated whole cells is 
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lacking, therefore, it is not clear why formalin inactivation has been successful while other 
inactivation methods have failed (Austin & Austin, 2016a).  
The best method of administration for fish vaccines has also been considered and a wide 
variety of methodologies have been investigated (Austin & Austin, 2016a).  These include: 
injection, oral uptake via food, immersion and bathing, spaying and showering, hyperosmotic 
infiltration, anal or oral intubation and ultrasonics/ultrasound (Austin & Austin, 2016a; Evelyn, 
1984).  While it is difficult to determine the most effective method most evidence suggests oral 
administration is the least effective vaccination method although some oral booster doses have 
been successful (Austin & Austin, 2016a).  While immersion has been shown superior to 
injection with some preparations, injection, with and without adjuvant, has been studied and in 
some cases may lead to higher antibody titres and thus, presumably better protection, although, 
antibody titre may not correlate directly with level of protection in all instances (Austin & 
Austin, 2016a).  Additional consideration for injection, as a vaccination method, include the need 
to anaesthetize fish prior to vaccination and although mass injection techniques are available this 
process is generally slow (Austin & Austin, 2016a).  Notably, vaccines against V. anguillarum 
and V. ordalii have been the focus of several studies due in large part to the commercial success 
of formalin-inactivated whole cell bacterins against these pathogens (Austin & Austin, 2016b).   
1.6 Vibrio anguillarum and Vibrio ordalii Bacterins and Immunogenicity 
Research 
Formalin inactivated V. anguillarum and V. ordalii bacterins are commercially available and 
the success of these vaccines in Atlantic halibut, African catfish, and sea bass has led to 
widespread use in aquaculture (Austin & Austin, 2016b).  However, a limited number of studies 
have been conducted to understand either the efficacy of these vaccines or the immune response 
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they elicit.  One study in Atlantic salmon conducted by Acosta, Lockhart, Gahlawat, Real, & 
Ellis (2004) demonstrated that a  V. anguillarum-V. ordalii bacterin induced the Type I interferon 
inducible Mx gene following intraperitoneal (i.p.) injection and that both purified 
deoxyribonucleic acid (DNA) and LPS from V. anguillarum serotype O1 induced Mx as well 
(Austin & Austin, 2016b).  In another study Joosten, Kruijer, & Rombout, (1996) demonstrated 
bacterin supernatant contains the most immunogenic component of the vaccine and it has been 
suggested that this immunogenicity is a an indication of heat-stable LPS in the cell wall that has 
been released into the culture supernatant (Austin & Austin, 2016b).  Furthermore, a 100kDa 
LPS is thought to be involved in the development of protection, although, two minor outer 
membrane proteins, approximately 49-51kDa in size, with strong antigenicity, as well as, a 
weakly antigenic protein, approximately 40kDa in size, may also contribute to bacterin 
immunogenicity (Austin & Austin, 2016b; Chart & Trust, 1984; Evelyn, 1984).  It is unclear if 
V. anguillarum or V. ordalii produce other non-LPS immunogens, however it has been 
demonstrated that preparations of O-antigen induce an immune response in a number of fish 
species including rainbow trout, and some work has suggested that both heat-labile and heat-
stable antigenic components play a role in immunogenicity, since formalin-killed vaccines 
provided better protection than heat-killed preparations in some studies (Austin & Austin, 2016b; 
Evelyn, 1984).  Potential flagella protein immunogenicity has also been evaluated in Japanese 
flounder (Paralichthys olivaceus) (Austin & Austin, 2016b).  Additionally, some research has 
focused on developing live-attenuated vaccines and while these have met with some success and 
may confer cross-protection against other pathogens, licensing these products for use in fisheries 
may be problematic (Austin & Austin, 2016b).  Consequently, LPS is one of the most important 
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vaccine components in V. anguillarum-V. ordalii bacterins and the majority are prepared from 
formalin-killed rather than heat-killed cultures (Colquhoun & Lillehaug, 2014; Evelyn, 1984).  
Moreover, the majority of vibriosis vaccines are bivalent V. anguillarum-V. ordalii 
inactivated whole cell bacterins, prepared for immersion or i.p. injection methods despite the 
convenience of oral vaccination (Austin & Austin, 2016b; Colquhoun & Lillehaug, 2014).  
Certainly many studies have focused on orally administered vaccines, including encapsulation to 
protect the vaccine from breaking down in the stomach and intestines, however, immersion and 
injection methods continue to out-perform oral vaccination (Austin & Austin, 2016b; Evelyn, 
1984).  In general, i.p. vaccination against vibriosis provides better and more durable protection 
than immersion vaccination, and it has been reported that vaccination by injection in a group of 
salmonids reduced mortalities to zero percent (Austin & Austin, 2016b; Colquhoun & Lillehaug, 
2014).   
1.6.1 Intraperitoneal Injection for Vibriosis Vaccination in Fish 
While i.p. injection of vaccines against vibriosis leads to superior and longer-lasting 
immunity this method is relatively costly in comparison to other methods and increases fish 
stress due to handling (Colquhoun & Lillehaug, 2014; Evelyn, 1984).  Additionally, it is 
inconvenient for vaccination of small fish, generally less than 20g, requires a large workforce for 
mass vaccination and is a slower process in comparison to alternative methods (Austin & Austin, 
2016b; Colquhoun & Lillehaug, 2014; Evelyn, 1984).  However, it is generally more feasible for 
large and/or valuable fish, it allows for even distribution and effective use of antigen, as well as, 
provides an opportunity to include adjuvants that enhance and prolong immunity (Austin & 
Austin, 2016b; Evelyn, 1984).  Additionally, some vaccines are only effective when 
administered via injection and this method has also been linked with an increase in skin mucus 
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antibody levels (Evelyn, 1984).  Furthermore, while alternative vaccination methods such as, 
immersion, often require repeated immersion vaccination and/or boosters, i.p. vaccination, 
especially with vaccines containing oil adjuvants, generally provides protection through to 
harvest in anadromous fish after a single i.p. injection (Colquhoun & Lillehaug, 2014).    
Another consideration, although one to bear in mind for any vaccination method, is the effect 
of temperature on the immune response of fish which, for V. anguillarum vaccination, is best 
documented for injection (Evelyn, 1984).  In general it seems antibody development is slower at 
lower temperatures following injection with killed V. anguillarum cells, while antibodies 
develop more quickly at warmer temperatures (Evelyn, 1984).  Thus, the effect of temperature 
must be taken into consideration when determining the best time to vaccinate fish to ensure 
immunity before exposure (Evelyn, 1984).  Generally, for commercially available vaccines a set 
of instructions lists the appropriate dose, method of administration, and details regarding any 
additional considerations.  For example, Vibrogen 2, a formalin-killed V. anguillarum serotypes I 
and II-V. ordalii bacterin, produced by Elanco Canada Limited, and licensed for use prior to 
2000 indicates the bacterin can be administered to healthy salmonids by i.p. injection in fish 10g 
or larger or by bath immersion in a one part bacterin to ten parts water bath for 30 seconds 
(Canadian Food Inspection Agency, 2017; Pridgeon & Klesius, 2012).  Additional information 
includes details concerning vaccine efficacy and states that vaccination is most effective when 
carried out at least 250 degree-days, calculated by multiplying the number of days post-
vaccination by the mean water temperature (oC), post-vaccination and if immunity is required for 





1.7 Challenges for Successful Fish Vaccine Development 
Despite the noted success of V. anguillarum and V. ordalii bacterins, little is understood 
regarding the immune response triggered in fish post-vaccination and many research programs 
for vaccines to important aquatic pathogens have not led to commercial products (Austin & 
Austin, 2016a).  This is likely due in large part to the general lack of available knowledge 
describing fish immunity (Dixon, 2012).  For example, little is known about the immunological 
pathways, such as inflammation, initiated as part of the innate immune response to pathogens, 
and how these activated pathways transition to the adaptive immune response for development of 
long term immunity.  However, what has been made clear from research conducted to date is that 
while the immune system of fish have machinery and immune components analogous to those 
found in mammals, the way the machinery and immune components work together differs in fish 
(Dixon, 2012).  Therefore, it is important fish vaccines be developed based on an understanding 
of the fish immune system rather than the mammalian system, and careful consideration of both 
the innate and adaptive immune pathways are critical for a complete understanding of long term 
immunity in fish (Dixon, 2012).    
1.8 Innate Immunity in Fish  
The innate immune response involves germ-line encoded and generally non-specific 
recognition of pathogens and is present in both invertebrates and vertebrates (Magnadottir, 2010; 
Rasmussen, Reinert, & Paludan, 2009).  This response is a rapid first line of defence and has 
adapted over time in response to environmental factors and pathogenic associations (Castro, Zou, 
Secombes, & Martin, 2011; Magnadottir, 2010; Rasmussen et al., 2009).  Thus, the innate 
immune response to pathogens is dependent on the evolutionary lineage and genetics of an 
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organism and any specificity gained over time is heritable (Magnadottir, 2010).  Despite a finite 
arsenal of machinery capable of pathogen recognition the innate immune response provides a 
strong and efficient defence against pathogens (Magnadóttir, 2006).  In fact, invertebrates rely 
solely on efficacy of innate immunity for protection against numerous pathogens across diverse 
environmental conditions (Magnadóttir, 2006).  There are three main components of innate 
immunity, these include: external physical barriers such as skin and mucous; humoral including 
antimicrobial peptides, complement and cytokines; and cell mediated including myeloid 
phagocytic cells (Romo, Perez-Marinez, & Ferrer, 2016).  Indeed, innate immunity relies heavily 
on white blood cells, such as macrophages and neutrophils, to kill pathogens via phagocytosis 
and simultaneously synthesize a broad range of inflammatory mediators and cytokines 
coordinating the additional responses necessary to combat invading pathogens (Aderem & 
Ulevitch, 2000).  Additionally, most vertebrates elevate body temperature by 1-4oC in a complex 
neuroendocrine and behavioural response known as fever, to aid the immune system by 
improving leukocyte efficacy and impairing microbial growth (Grans, Rosengren, Niklasson, & 
Axelsson, 2012).  Moreover, the innate immune system is necessary for activation of acquire or 
adaptive immunity (Magnadóttir, 2006; Rasmussen et al., 2009).   The characteristics of teleost 
fish innate immunity are, for the most part, shared by invertebrates as well as higher vertebrates 
and the innate immune response of fish is generally divided into three: the epithelial/mucosal 
barriers including the skin, gills and alimentary tract; the humoral parameters expressed as cell 
receptors and soluble secreted forms including complement; and the cellular component 
including important innate immune cells such as monocytes/macrophages (Magnadottir, 2010; 
Magnadóttir, 2006).  Notably, while mammals and birds increase body temperature via a 
complex internal thermoregulatory process to elicit fever, fish, including rainbow trout, have 
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been shown to seek out warmer water to induce a behavioural fever during immunostimulation 
and in goldfish (Carassius auratus) increased water temperatures improved survival of infected 
fish (Grans et al., 2012). 
1.8.1 Pattern Recognition Receptors 
Once a pathogen has penetrated the physical protective barriers of the innate immune system 
such as the skin, the germ-line encoded pattern recognition receptors (PRRs) are responsible for 
recognizing exogenous conserved motifs, known as, pathogen associated molecular patterns 
(PAMPs) such as LPS and flagellin, as well as, endogenous cellular debris and components 
generated by cellular damage, known as, danger associated molecular patters (DAMPs) (Castro 
& Tafalla, 2015; Chettri, Raida, Holten-Andersen, Kania, & Buchmann, 2011; Rebl, 
Goldammer, Fischer, Köllner, & Seyfert, 2009; Tanekhy, 2016).  PRRs are primarily located on 
dendritic cells (DCs) and macrophages, however, they are also present on additional cell types 
including, B cells and endothelial cells, and once activated PRRs trigger several intracellular 
activation pathways that ultimately all lead to activation of pro-inflammatory genes or anti-
microbial genes (Castro & Tafalla, 2015).  In teleosts, five PRRs types have been identified; C-
type lectin receptors, NOD-like receptors, RIG-I-like receptors and peptidoglycan recognition 
proteins, however, Toll-like receptors (TLRs) are the most studied and well known (Castro & 
Tafalla, 2015).  TLRs are important to both innate and adaptive immunity with activation leading 
to the production of inflammatory cytokines, which are small glycoproteins or simple 
polypeptides of less than 30kDa, responsible for regulating immune function by mediating cell 
signaling, as well as, induction of major histocompatibility complex (MHC) class II in mammals 
(Castro & Tafalla, 2015; Secombes, Hardie, & Daniels, 1996; Tanekhy, 2016).  More than 17 
TLRs have been identified in fish and while some appear similar to those in mammals some are 
25 
 
unique to teleosts (Castro & Tafalla, 2015; Tanekhy, 2016).  Indeed, a high degree of TLR 
recognition and function appears to be conserved between mammals and fish, however, notable 
differences include TLR4, that in mammals recognizes LPS, however in some fish TLR4 is 
unable to recognize LPS and in other fish TLR4 is absent altogether, and TLR3 in fish, appears 
to recognize both bacterial and viral PAMPs, while mammalian TLR3 recognizes only viral 
PAMPs (Castro & Tafalla, 2015; Tanekhy, 2016). Additionally, while both mammalian and fish 
TLR5 appear to recognize bacterial flagellin, in several fish species including rainbow trout, a 
TLR5-like soluble protein that binds flagellin has also been reported and this soluble form is 
absent in mammals (Tanekhy, 2016; Tsujita et al., 2006). Irrespective of these difference TLRs 
in fish are a key part of the innate immune response and are involved in initiating the pro-
inflammatory response.  
1.8.2 Inflammation 
The inflammatory response involves a variety of cell types, such as, macrophage and DCs, as 
well as, the attraction of leukocytes to an inflamed area in a complex and multi-step process 
under strict regulatory control by cytokines (Secombes et al., 2001; van der Aa, Chadzinska, 
Golbach, Ribeiro, & Lidy Verburg-van Kemenade, 2012).  Indeed, the acute inflammatory 
response is characterized by the transport of blood components such as plasma and leukocytes to 
sites of microbial infection via a process triggered by innate immune receptors (Medzhitov, 
2008).  This initial pathogen recognition event is mediated by macrophage and mast cells present 
in the tissue at the site of infection and leads to the production of pro-inflammatory mediators 
such at chemokines and cytokines (Medzhitov, 2008).  That is, when PRRs such as TLRs bind 
PAMPs, a series of intracellular signaling pathways that lead to production and release of pro-
inflammatory cytokines such as, tumor necrosis factor alpha (TNFα) and interleukin 1β (IL-1β) 
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are initiated (Fierro-Castro et al., 2012).  The primary and direct effect of these pro-inflammatory 
cytokines, along with other pro-inflammatory mediators such as chemokines, vasoactive amines, 
eicosanoids and proteolytic cascade products is to induce an inflammatory exudate at the site of 
infection allowing plasma proteins and leukocytes such as neutrophils access to the extravascular 
tissues at the infection site (Medzhitov, 2008).  Once neutrophils reach the site of infection they 
are activated by the invading pathogen or cytokines and will attempt to eliminate the invading 
pathogen (Medzhitov, 2008).  However, neutrophil activity relies on the release of toxic 
contents, such as reactive oxygen species and reactive nitrogen species, from their granules and 
this process results in damage to host tissues as neutrophils are unable to differentiate between 
microbial and host targets therefore, a resolution and repair phase, mediated by recruited and 
tissue-resident macrophages, follows clearance of the infectious agent as part of a successful 
acute inflammatory response (Medzhitov, 2008).  It has been demonstrated that the pro-
inflammatory response of teleosts is similar to the response observed in mammals and is 
biphasic, beginning with an influx of neutrophils followed by the arrival of monocytes and/or 
macrophages, however, it appears to be less intense and both slower to appear and resolve (Finn 
& Nielson, 1971; Reite & Evensen, 2006).  Additionally, it is well understood that in mammals, 
activation of the inflammatory response leads to a cytokine cascade that begins with the release 
of TNFα, and is followed by IL-1β production which is followed by release of interleukin 6 (IL-
6) (Secombes et al., 2001).  Characterization of rainbow trout TNFα bioactivity demonstrated 
that recombinant TNFα (rTNFα) induces expression of several pro-inflammatory genes, 
including IL-1β, in both head kidney leukocytes and macrophages, as well as, enhances 
leukocyte migration in vitro and regulates phagocytosis of head kidney leukocytes, while 
characterization of rainbow trout IL-1β showed recombinant IL-1β (rIL-1β) increases the 
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expression of important downstream genes including MH class II β chain, as well as, the 
phagocytic activity of head kidney leukocytes (Hong et al., 2001; Zou et al., 2003)   
1.8.3  Interleukin 1β 
Interleukin 1β was the first cytokine cloned in fish and has been identified in several teleost 
species including salmonids (Angosto et al., 2014).  In mammals, IL-1β has a range of biological 
effects, a broad range of target cells and plays a fundamental and central role in both the 
initiation and regulation of inflammation (Peddie, Zou, Cunningham, & Secombes, 2001).  The 
mammalian IL-1β protein is characterized by an IL-1 converting enzyme (ICE) cut site where 
caspase-1 cleaves the IL-1β inactive precursor to generate the biologically active mature form 
(Hong, Zou, Collet, Bols, & Secombes, 2004).  Additionally, in mammals, it is understood that 
activation of inflammatory caspases, such as caspase-1 is dependent on cytosolic multiprotein 
platforms called inflammasomes (Angosto et al., 2012).   
Four distinct inflammasome compositions have been identified in mammals three of which 
contain the nucleotide-binding and oligomerization domain-like receptors (NLRs): NLRP1B, 
NLRP3 and NLRC4 (Angosto et al., 2012).  The NLRP3 inflammasome is well characterized 
and the best studied inflammasome and it has been shown that this inflammasome is not 
evolutionarily conserved and is specific to mammals (Ogryzko, Renshaw, & Wilson, 2014).  In 
fact, Angosto et al., (2012) demonstrated that stimulated or infected gilthead seabream (Sparus 
aurata) macrophages process and release IL-1β independent of caspase-1, and while the IL-1β 
cytokine identified in fish has similar biological function to mammalian IL-1β, including 
regulation of the inflammatory response, fish IL-1β lacks the ICE cut site (Hong et al., 2001; 
Hong et al., 2004; Zou, Grabowski, Cunningham, & Secombes, 1999).  However, despite the 
absence of the ICE cut site in the fish IL-1β sequence Zou et al., (1999) predicted, based on 
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multiple sequence alignment, that the rainbow trout IL-1β precursor is cleaved at Ala95 (alanine 
95) and it has been demonstrated that although fish appear to lack NLRP3, the NLR protein 
expansion of teleosts is similar to a family of proteins found in sea urchin (Ogryzko et al., 2014).  
Nevertheless, strong evidence suggests that rainbow trout IL-1β is processed by macrophage 
cells, and cleavage of precursor IL-1β occurs within the cell to produce the mature active form, 
which is released from the cells as part of the processing event or after processing has occurred 
(Hong et al., 2004). 
1.8.4  Macrophages 
Macrophages are present in nearly every cell where they are responsible for maintaining 
balance and are generally among the first cells to recognize invading pathogens (Hodgkinson, 
Grayfer, & Belosevic, 2015).  Additionally, macrophages are responsible for coordinating 
appropriate immune responses (Hodgkinson et al., 2015).  In mammals four different 
macrophage subset populations have been described including one classically activated 
population type and three alternatively activated types (Hodgkinson et al., 2015; Wiegertjes, 
Wentzel, Spaink, Elks, & Fink, 2016).  Classically activated macrophages (M1) are stimulated 
by interferons (IFNs) and TNFα and alternatively activated macrophages are activated by; 
interleukin 4 (IL-4) and interleukin 13 (IL-13) (M2a) or, immune complexes or apoptotic cells 
(M2b), or are deactivated by interleukin 10 (IL-10), transforming growth factor β (TGF-β) or 
glucocorticoids (M2c) (Hodgkinson et al., 2015; Wiegertjes et al., 2016).  In fish, macrophages 
appear to be the primary antigen presenting cell although DCs have been identified in some fish 
species, and activation of teleost macrophages comparable to M1 classically activated 
macrophages in mammals, is the most studied and well characterized macrophage population 
type in fish (Hodgkinson et al., 2015; Magnadottir, 2010).  Macrophages in fish are responsible 
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for rapidly killing invading pathogens by phagocytic activity, a process where pathogens are 
engulfed and toxic reactive intermediates are produced, by phagolysosomal acidification and by 
restriction of nutrient availability (Hodgkinson et al., 2015; Wiegertjes et al., 2016).  In addition 
to pathogen clearance phagocytosis is also required for antigen presentation (Castro & Tafalla, 
2015).  Moreover, classically activated macrophages are responsible for producing cytokines, as 
well as, chemokines and lipid mediators that enhance and regulate both the inflammatory 
response and the adaptive immune response (Hodgkinson et al., 2015).   Furthermore, in 
mammals, interferon γ (IFNγ) plays an important role in macrophage activation and is 
considered an important pro-inflammatory cytokine responsible for M1 macrophage activation 
(Hodgkinson et al., 2015; Wiegertjes et al., 2016).  In fact, M1 polarization of macrophages is 
achieved primarily by IFNγ activity, however, to fully stimulate M1 macrophage activity, co-
stimulation with TNFα is required (Hodgkinson et al., 2015).   
1.8.5  Interferon γ 
Interferon γ, a type II interferon, is primarily produced and secreted by natural killer (NK) 
cells and T cells, is generally considered a T helper cell 1 (Th1) cytokine, and is responsible for 
macrophage activation, mediating leukocyte migration, enhancing antigen presentation and 
inducing T cell differentiation in mammals (Martin, Zou, Houlihan, & Secombes, 2007; Zou, 
Carrington, Collet, Dijkstra, Yoshiura, Bols, & Secombes, 2005).  Additionally, Darwich et al., 
(2009) demonstrated that human macrophages, stimulated by interleukin 12 (IL-12) and 
interleukin 18 (IL-18) produce IFNγ in the absence of both a T cell response and NK cells.  This 
cytokine has been identified and characterized in fish and Zou et al. (2005) demonstrated that 
recombinant IFNγ (rIFNγ) enhances respiratory burst activity in macrophages and induces 
expression of IFNγ inducible protein 10 (γIP-10) and MH class II β chain suggesting the 
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bioactivities of rainbow trout IFNγ are similar to that of mammalian IFNγ.   IFNγ has also been 
shown to upregulate antiviral effector genes such as Mx in fish and is a strong inducer of pro-
inflammatory cytokines such as IL-1β (Wang & Secombes, 2013; Zou & Secombes, 2016).  
Furthermore, in addition to evidence supporting IFNγ involvement in MH class II antigen 
presentation, global transcriptome analysis has revealed IFNγ up-regulates genes involved in MH 
class I presentation (Wang & Secombes, 2013; Zou & Secombes, 2016).  Overall, the evidence 
suggests that IFNγ in teleosts plays an important regulatory role in both the innate and adaptive 
immune response (Zou & Secombes, 2016) 
1.9 Adaptive Immunity in Fish 
The adaptive immune response is considered an evolutionarily more recent defence system, 
and is thought to have first appeared in the jawed vertebrates, primitive fishes, about 400 to 500 
million years ago (Magnadottir, 2010).  The main components of the adaptive immune system 
that have developed through evolutionary time are the thymus, B-cells and T-cells, and the 
recombination activation gene (RAG) which is responsible for generating immunoglobulin 
superfamily diversity through gene rearrangement (Magnadottir, 2010).  The immunoglobulin 
superfamily includes B-cell receptors, T-cell receptors and MHC receptors, all of which are 
generated somatically during ontogeny and are therefore not germ-line encoded (Magnadottir, 
2010).  The nature of the adaptive immune system allows for a specific response that reflects the 
immune experience of an individual and thus is not heritable (Magnadottir, 2010).  While the 
adaptive response is specific, this response system generally develops slowly and requires a 
series of events including specific receptor selection, cellular proliferation, as well as, protein 
synthesis for activation, however, the adaptive response is also characterized by memory and 
therefore provides long term immunity (Findly, Zhao, Noe, Camus, & Dickerson, 2013; 
31 
 
Magnadottir, 2010; Wilson, 2017).  The immunoglobulins (Igs), or antibodies, are essential to 
humoral adaptive immunity and are expressed as B-cell receptors or are secreted in the plasma 
however, both B-cells and T-cells, which are involved in cell mediated immune responses, are 
responsible for specifically recognizing pathogens and initiating an adaptive immune response 
(Magnadottir, 2010).  While B-cells are activated following recognition of either soluble antigen 
or antigen associated with MHC on an antigen presenting cell, T-cells only recognize antigen 
associated with MHC receptors on antigen presenting cells (Magnadottir, 2010).   It appears that 
fish have the basic machinery and features of the vertebrate adaptive immune system although 
there are some differences observed, for example the antibody repertoire of fish which includes 
IgM and IgD, as well as IgT, or IgZ in some species, seems to lack IgG, IgA and IgE isotypes 
and thus appears to be limited in comparison to mammals (Findly et al., 2013; Magnadottir, 
2010; Mashoof & Criscitiello, 2016; Wilson, 2017).  Additionally, isotype switching or class-
switch recombination does not occur in bony fish and while MH genes have been identified in 
several fish species the genes are not found as a complex on a single chromosome in teleost fish 
as they are in mammals, and instead are spread over three or four genomic locations, therefore in 
fish, they are designated MH genes rather than MHC genes (Findly et al., 2013; Fujiki, Smith, 
Liu, Sundick, & Dixon, 2003; Magnadottir, 2010; Wilson, 2017).  Furthermore, immunological 
memory in teleost fish is a topic of contention and the role of teleost B-cells and plasma cells in 
adaptive memory is poorly understood (Findly et al., 2013; Parra, Reyes-Lopez, & Tort, 2015).   
Overall, the adaptive immune response of fish appears to be slower than that of mammals 
and, following vaccination, specific antibody titres remain below detectable levels until week 
three or four in fish (Parra et al., 2015).  Additionally, Findly et al., (2013) observed that in 
channel catfish infected and challenged with Ichthyophthirius multifiliis antigen specific plasma 
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cells do not persist for more than about one year while IgM, memory B-cells are sustained for at 
least three years.  Moreover, while affinity maturation of teleost B-cells exists, as does clonal 
expansion, leading to protection by memory response for several years post-vaccination, 
antibody affinity increases marginally in fish compared to antibody affinity in mammals which is 
known to increase logarithmically (Parra et al., 2015).   
1.9.1 Major Histocompatibility Class I 
In mammals MHC class I molecules are present on almost every nucleated cell and are 
responsible for binding endogenous proteins that are generated through degradation by 
proteasomes in the cytosol (Castro & Tafalla, 2015; Sever, Vo, Bols, & Dixon, 2014).  Peptides 
produced by proteasome degradation enter the lumen of the endoplasmic reticulum via the 
transporter associated with antigen processing (TAP) as part of the MH class I antigen 
presentation pathway (Sever, Vo, Bols, et al., 2014).  Therefore, the MH class I receptor 
generally presents intracellular antigens produced during an infection by virus or intracellular 
bacteria or those produced as a result of cellular damage or dysfunction, to CD8+  T-cells (Castro 
& Tafalla, 2015; Sever, Vo, Bols, et al., 2014).  However, evidence of cross-presentation, or the 
presentation of exogenous antigen by MHC class I, has been reported (Goodridge et al., 2013).  
In fish MH class I is up-regulated in response to pathogens and immunostimulants, and 
expression of important MH class I accessory proteins and genes including TAP1, tapasin, 
calnexin, calreticulin and ERp57, primarily in response to viral pathogens or viral mimics, have 
also been investigated, however, many of the details surrounding MH class I antigen presentation 
in fish remains a mystery (Castro & Tafalla, 2015; Martin et al., 2007; Sever, 2014; Sever, Vo, 
Bols, et al., 2014; Sever, Vo, Lumsden, Bols, & Dixon, 2014) 
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1.9.2  Major Histocompatibility Class II 
Mammals only express MHC class II receptors on professional antigen presenting cells such 
as macrophages, DCs, and B-cells, and present phagocytosed extracellular proteins to CD4+  T 
helper cells (Castro & Tafalla, 2015; Fujiki et al., 2003).  This generally occurs in the spleen or 
lymph nodes of mammals (Castro & Tafalla, 2015).  In mammals MHC class II is associated 
with invariant chain (Ii) in the endoplasmic reticulum where the class II associated invariant 
chain peptide (CLIP) binds the MHC class II receptor groove ensuring the receptor does not bind 
intracellular proteins (Fujiki et al., 2003).  Once the Ii-MHC class II complex fuses with a 
lysosome that contains exogenous antigen the Ii chain is fragmented by proteases and the CLIP 
is replaced with exogenous antigen while a dedicated molecular chaperone, HLA-DM in 
humans, removes the active component of the Ii chain from the peptide binding region and 
stabilizes the molecule (Fujiki et al., 2003; Wilson, 2017).  Finally, the MHC class II receptor 
bound with extracellular antigen moves to the cell surface where it presents the bound antigen to 
T helper cells and initiates the adaptive humoral immune response (Fujiki et al., 2003).  In fish 
up-regulation of MH class II following exposure to pathogens or immunostimulation has been 
observed and multiple invariant chain genes have been identified while a DM analog is absent in 
teleosts (Castro & Tafalla, 2015; Christie, 2007; Fujiki et al., 2003; Wilson, 2017).  Three 
invariant chain genes have been identified in rainbow trout: 14-1, S25-7 and INVX, however, it 
is unclear the role each may play in the adaptive immune response of salmonids (Christie, 2007; 





1.10 Reverse Transcriptase Relative Quantitative Polymerase Chain   
    Reaction 
Amplification of complementary deoxyribonucleic acid (cDNA) prepared by reverse 
transcription (RT) of messenger ribonucleic acid (mRNA) by quantitative real-time polymerase 
chain reaction (qPCR) is a tool in molecular biology commonly used to study low abundance 
gene expression (Pfaffl, 2001).  This popular technique is highly sensitive allowing 
quantification of both rare transcripts and small changes in the expression of genes, and provides 
desired levels of accuracy, as well as, rapidly generates results (Pfaffl, 2001).  The use of SYBR 
Green I, a fluorescence dye that binds to the minor groove double stranded DNA, is a simple 
technique for detecting products that have been synthesized by qPCR (Pfaffl, 2001).  There are 
two types of quantification generally conducted by RT-qPCR; relative quantification, which is 
based on the relative expression of a gene of interest compared to a reference gene, and absolute 
quantification, which is based on the expression of a gene of interest compared to an internal or 
external calibration curve (Pfaffl, 2001).  Given that development of absolute quantification is 
time consuming and requires the design and production of standard material along with 
optimization and validation of the calibration curve, as well as, normalization to an endogenous 
reference gene, relative quantification is an attractive alternative (Pfaffl, 2001).   A calibration 
curve is not required for relative quantification and a relative expression ratio is calculated from 
the qPCR efficiency and the difference between the crossing point (Cp) of the unknown sample 
verses the Cp of a control (Pfaffl, 2001).  Thus, relative qPCR using the Roche LightCycler and 
SYBR Green I is a sensitive and rapid method for detecting low levels of mRNA transcript and 
provides a convenient method for elucidating the mRNA expression levels of important immune 




Vibrogen 2, is among the few commercially available vaccines licensed for use in 
aquaculture and confers immunity to V. anguillarum and V. ordalii, the causative agents of the 
economically devastating fish disease, vibriosis.  Use of this vaccine, as well as other, V. 
anguillarum-V. ordalii bacterins, plays a key role in successful control of vibriosis in 
aquaculture, however, the reason behind the success of these vaccines is poorly understood.  
Furthermore, the immunological pathways leading to long-term immunity remain unclear in fish.  
The main goals of this work are to determine the type of immune response triggered by the 
commercially available bacterin, Vibrogen 2, and investigate the early response of rainbow trout 
at the innate/adaptive immunity interface to better understand how immunity to V. anguillarum 
and V. ordalii is conferred by Vibrogen 2, as well as, the transition from innate to adaptive 
immunity in fish through the investigation of some of the genes up-regulated during the first 24h 















Induction of IL-1β, IFNγ, S25-7 and TAP1 in RTS11 Cells by the 
Vibrogen 2 Vaccine 
 
2.1  Introduction 
The monocyte/macrophage like RTS11 cell line has been widely used for in vitro studies 
aiming to understand the immune response of rainbow trout.  This cell line, established from a 
haemopoietic rainbow trout spleen culture, was characterized by Ganassin and Bols, (1998) and 
is comprised of two cell types including a population of small round non-adherent cells and a 
population of larger granular cells that are both adherent and non-adherent, however the culture 
primarily consists of the latter.  Characterization of the larger cell type suggests that these cells 
are macrophages while the smaller round cell population represents cells at an earlier stage of 
development and these cells are thought to be macrophage precursor cells (Ganassin & Bols, 
1998).  Immunological studies investigating the gene expression of pro-inflammatory cytokines 
including IL-1β and IFNγ, as well as, the expression of MH class I, MH class I accessory 
proteins, including TAP1, and MH class II and MH class II accessory proteins, including S25-7, 
in RTS11 cells, have been described previously (Christie, 2007; Fujiki et al., 2003; Hong et al., 
2004; Martin et al., 2007; Sever, 2014; Sever, Vo, Bols, et al., 2014; Sever, Vo, Lumsden, et al., 
2014; Zou, et al., (2005).  Notably, despite reports of IFNγ production by human macrophage 
cells expression of IFNγ by RTS11 cells has not been reported to date (Darwich et al., 2009).  
The aim of this study is to understand the innate/adaptive immune response interface in fish 
macrophages in response to the Vibrogen 2 vaccine to elucidate the immunological response 
triggered in rainbow trout following vaccination and to better understand the immune response 
37 
 
of fish.  As this vaccine is among the few successful and commercially available vaccines 
understanding the effect of this vaccine on macrophages may shed light on the immunological 
pathways initiated and provide information useful for production of effective vaccines to 
additional pathogens.  It is hypothesized that after stimulation with Vibrogen 2, RTS11 cells, will 
first transiently up-regulate the pro-inflammatory cytokine IL-1β gene leading to up-regulation 
of the IFNγ gene, a key cytokine of the adaptive immune response.  This will be followed by up-
regulation of S25-7 transcript, an MH class II associated invariant chain, but not TAP1 
transcript, an MH class I associated transporter protein. 
2.2   Materials and Methods 
2.2.1 Maintenance of RTS11  
RTS11 cells were maintained in Leibovitz’s L-15 media (Hyclone) with 20% fetal bovine 
serum (FBS, Gibco) and 1% penicillin/streptomycin (Hyclone) at room temperature.  Routine 
maintenance was carried out according to the methods previously described by Sever, Vo, Bols, 
& Dixon, (2014).  Briefly, RTS11 cells were grown in 25cm2 tissue culture flasks (BD Falcon) 
and sub-cultured without the use of trypsin at 1:2 where half the conditioned medium with 
suspended cells was passaged to a new flask and equal volumes of fresh media added to each of 
the two flasks.  Once flasks reached confluency, approximately 2ml of fresh media was added 
about every three to four weeks.  
2.2.2 Cell Collection and Plating 
RTS11 cells from multiple confluent 25cm2 flasks were collected by transferring 
conditioned media and cells to a sterile 50mL conical tube with a sterile plastic transfer pipette.  
Adherent cells were removed by washing conditioned media over the surface of the bottom of 
38 
 
the flask using the transfer pipette.  Approximately, 1mL of sterile Dulbecco’s phosphate 
buffered saline (DPBS, Lonza) was then added to the flask and a transfer pipette was used to 
further wash cells from the flask and transfer the DPBS to the 50mL conical tube.  The RTS11 
cells were pelleted by centrifugation at 4oC for 5min at 550 x g.  Cells were then washed once 
with fresh media supplemented with 2% FBS plus 1% penicillin/streptomycin and pelleted by 
centrifugation as described above.  Washed cell pellets were resuspended in fresh media 
containing 2% FBS and 1% penicillin/streptomycin and counted with a hemocytometer.  Cells 
were plated in three wells of a four well cell culture plate (Nunc) at 7 X 106 cells per well.  Plates 
were then placed at 18oC for 48h.     
2.2.3  In vitro RTS11 Trials  
After 48h at 18oC, RTS11 cells had become adherent and conditioned media was 
removed by aspiration and replaced with 3mL of fresh media containing 2% FBS and 1% 
penicillin/streptomycin with or without an immunostimulant.  Three control wells and three 
wells for each treatment were prepared for each of three time points: 4h, 8h, and 24h.  Control 
wells received 3mL of fresh media containing 2% FBS and 1% penicillin/streptomycin and 
treatment wells received 3mL of 1:100 Vibrogen 2 or 1:500 Vibrogen 2 diluted in fresh culture 
media containing 2% FBS and 1% penicillin/streptomycin.   
At each time point, cells were photographed and conditioned media and cells were 
collected.  Briefly, 1mL of conditioned media was removed and transferred to a low protein 
binding 1.5mL microfuge tube and was placed on ice.  Then a clean cell scraper was used to 
mechanically lift the cells from the bottom of the well.  The conditioned media containing cells 
was transferred to a 15mL conical tube, 1mL of DPBS was added to the well, and the cell scraper 
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was used to collect remaining cells.  After the 1mL of DPBS containing cells was transferred to 
the appropriate 15mL conical tube, the tube was centrifuged at 4oC for 4min at 500 x g to pellet 
the cells.  The supernatant was poured off and the pellet was washed twice with 5mL of DPBS.  
Centrifugation between washes was carried out as above.  After the second wash, DPBS was 
poured off and the cell pellet was resuspended by pipetting up and down in the residual DPBS, a 
volume of about 100μl, and transferred to a low protein binding 1.5mL microfuge tube.  Samples 
were then centrifuged at 4oC for 5min at 500 x g, the DPBS was pipetted off and the tubes were 
transferred to ice.  Conditioned media and cell pellets were then stored at -80oC until processing.     
2.2.4 Ribonucleic Acid and Protein Extraction  
Total ribonucleic acid (RNA) was extracted from cell pellets using the Norgen RNA and 
Protein Plus purification kit according to the manufacturers’ specifications except that, RNA was 
eluted in 30µl of molecular biology grade water (Fisher) rather than 50µl of elution buffer.  In 
brief, each cell pellet was homogenized in lysis buffer and column purification was carried out to 
remove genomic deoxyribonucleic acid (gDNA).  RNA was then column purified and the flow 
through containing protein extract was retained for future analysis.  Both RNA pellets and 
protein extracts were placed on dry ice immediately after isolation and then transferred to a -
80oC freezer for storage.    
2.2.5 Ribonucleic Acid Quantification and Purity  
RNA pellets were removed from storage at -80oC and placed on ice.  Samples were left to 
thaw on ice and were then mixed by flicking and pulse centrifugation.  The purity and quantity of 
each RNA sample was determined using a BioTek microplate spectrophotometer Take3.  In 
brief, 3μl of molecular biology grade water was loaded in the first well as a blank and 3μl of 
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each RNA sample was loaded in subsequent wells followed by RNA quantification using the 
BioTek RNA nucleic acid quantification program for the Take3.  The 260/280 ratio was recorded 
and the quantity of RNA was reported in ng/µl.   
2.2.6 cDNA Synthesis 
 cDNA was prepared using the Maxima H Minus First Strand cDNA Synthesis Kit, with 
dsDNase, (Thermo Fisher Scientific) according to the manufacturer directions for downstream 
use in qPCR.  Briefly, 1μg of total RNA was added to 2µl dsDNase mix and nuclease free water 
was added to bring the final reaction volume to 10µl.  Tubes were placed in a T100 thermocycler 
(BioRad) for 2min at 37oC to remove any residual gDNA.  Samples were pulse centrifuged and 
returned to ice and the random hexamer primer and dNTP mix, along with nuclease free water, 
were added, bringing the reaction volume to 15µl.  The optional GC rich incubation step was 
performed and samples were incubated at 65oC for 5min in the T100 thermocycler. Samples 
were once again pulse centrifuged and returned to ice for the addition of RT reagents, including 
1µl of Maxima H Minus enzyme mix and 4µl of 5X RT buffer.  The 20µl reactions were loaded 
into the T100 thermocycler for cDNA synthesis and incubated for 10min at 25°C followed by 
15min at 50°C and then the reaction was terminated by heating at 85°C for 5min.  For each run, a 
negative control without the RT enzyme was included.  Samples were stored at -80oC for future 
use. 
2.2.7 Quantitative Polymerase Chain Reaction 
cDNA was removed from storage at -80oC and placed on ice to thaw.  cDNA was flicked to 
mix and then pulse centrifuged.  SYBR reactions were prepared for each sample using 
LightCycler 480 SYBR Green Master I (Roche).  Briefly, a reaction master mix was prepared for 
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each primer set to be included on a 96-well plate and included 5μl of 2X SYBR Master Mix, 
2.5μl of 2μM primer stock containing both forward and reverse primers (Table 3-1), and 1.5µl 
nuclease free PCR-grade water.  The final concentration of primer in the mix was 0.5μm.  To 
each 9µl aliquot of reaction master mix, 1µl cDNA template was added.  A stable reference gene 
was identified using BestKeeper (Pfaffl, Tichopad, Prgomet, & Neuvians, 2004) and a standard 
curve for the best reference gene, elongation factor 1 alpha (EF1α), as well as each target gene 
was generated to determine primer efficiency.  Serial dilutions of pooled cDNA from head 
kidney sample V8B were used to generate each standard curve.  Primer pairs used for EF1α, as 
well as, target genes: IL-1β and IFNγ; were previously published by Chettri, Raida, Holten-
Andersen, Kania, & Buchmann, (2011) however to confirm specificity in RTS11 cells a qPCR 
product for each primer pair was run on a 2% agarose gel containing GelRed (Biotium) and 
visualized using ultraviolet light.  All unknown samples were run in triplicate and each 96-well 
plate included all samples for one time point with each sample being run with the reference gene, 
EF1α, primers as well as one set of target gene primers. Controls included no template control 
(NTC) negatives and a positive calibrator on each 96-well reaction plate.  The LightCycler 480 
(Roche) SYBR Green I 96-II template provided by the LightCycler 480 software was used 
according to the default parameters except the pre-incubation time was increased to 10min.   
Table 3-1: Reference and target gene primers and expected product size of each amplicon 
 Forward Reverse Amplicon (bp) 
Accession 
Number 
EF1α 5’ACCCTCCTCTTGGTCGTTTC 5’TGATGACACCAACAGCAACA 63 AF498320 
IL-1β 5’ACATTGCCAACCTCATCATCG 5’TTGAGCAGGTCCTTGTCCTTG 91 AJ223954 
IFNγ 5’AAGGGCTGTGATGTGTTTCTG 5’TGTACTGAGCGGCATTACTCC 68 AY795563 
S25-7 5’GTTCCTGGCCAACCTACAGA 5’CCAATTACGTGCCCAAGTCT 82 AY065836 






For all reaction plates, advanced relative quantification using the LightCycler 480 software 
was performed using the primer efficiency of the reference and target genes as determined by the 
standard curve for each primer pair.  This was followed by normalization of the control group to 
one and calculation of fold-change for each treatment group relative to the control.  Additionally, 
statistical and graphical analysis was performed using GraphPad software.  Two-way ANOVA 
analysis was used to determine the interaction between treatments over time.  
2.3   Results 
2.3.1 Morphology Changes, and Proliferation and Differentiation of RTS11 
Cells in Response to Vibrogen 2 
Qualitative observations reveal that stimulation of RTS11 cells with Vibrogen 2 leads to 
minimal changes in the morphology of cells stimulated with either a 1 in 100 or 1 in 500 dilution 
of Vibrogen 2 at 4h and 8h respectively (Figure 2-1).  However, at 24h post-stimulation it 
appears that wells containing cells stimulated with either dilution have a greater number of 
elongated and adherent cells in comparison to the 24h control where cells appear to 
predominantly remain in suspension and maintain a rounded monocyte-like morphology (Figure 
2-1).  The elongated and adherent cells observed are likely monocyte-like cells that have 
undergone differentiation.  Thus, the greater number of cells exhibiting these features in wells 
24h post-stimulation appears to correlate with the addition of Vibrogen 2 combined with 
sufficient time post-stimulation for differentiation to occur (Figure 2-1).   However, it is 
important to note that the observations in different fields of view may not reflect the same 
abundance of differentiated cells at 24h, and at both 4h and 8h, fields of view with varied 
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abundance of differentiated cells were observed.  Additionally, it appears that there is a greater 
number of cells present at 24h, than that observed at 4h and 8h respectively, and that there is a 
greater number of cells present in stimulated wells compared to control wells at 4h and 8h 
respectively.   However, the semi-adherent nature of RTS11 cells, along with the design of the 
four-well tissue culture dish affected the distribution of cells in the well and cells were not 
evenly distributed in the well.  In fact, cells were consistently more abundant around the edges of 
the well and became less abundant moving towards the centre of the well.  Additionally, during 
preliminary work cell counts were carried out and it was determined that 72h post-stimulation 
there was no significant difference in the number of cells present in the 72h control well versus 




























Figure 2-1: Control and stimulated RTS11 cells.  Photographs at 100X magnification of 
control RTS11 cells at 4h, 8h and 24h, and RTS11 cells stimulated with Vibrogen 2 diluted in 
culture media to 1 in 100 or 1 in 500 at 4h, 8h and 24h, for visual comparison of cell 
morphology, cell abundance and cell differentiation.   
 
2.3.2 Normalized ratios of IL-1β, IFNγ, S25-7 and TAP1 in RTS11 Cells 
Stimulated with Vibrogen 2 Demonstrate Patterns in Gene Expression 
Profiles 
Relative qPCR focused on expression of four genes of interest: IL-1β, IFNγ, S25-7, and 
TAP1, in RTS11 cells stimulated with Vibrogen 2, diluted in culture media to 1 in 100 or 1 in 
4h 





500, provides a normalized ratio representative of the expression of each gene of interest relative 
to the expression of the EF1α reference gene.  These normalized ratios when plotted graphically 
(Figure 2-2) demonstrate the generally low variability of gene expression from well to well, 
allow for the identification of outliers and illustrate the gene expression trends for each gene over 
time.  In Figure 2-2, the normalized ratios for IFNγ expression group together across control 
cells and both Vibrogen 2 treatments and it appears there is one outlier, that is approximately 1.1 
normalized ratio units above the next nearest control normalized ratio, in the control group at 4h.   
For IL-1β, S25-7 and TAP1 replicate wells grouped consistently across treatments and time 
(Figure 2-2).  Stimulation with the more concentrated 1 in 100 Vibrogen 2 resulted in higher 
levels of expression for IL-1β at 4h, 8h and 24h, at 24h for S25-7, and at 8h for TAP1, compared 
to stimulation with the higher 1 in 500 Vibrogen 2 dilution which resulted in lower expression 
levels.  The difference between the expression levels of cells stimulated with 1 in 100 Vibrogen 
2 versus 1 in 500 Vibrogen 2, appears to be consistent and translates to nearly a fivefold change 
in expression for IL-1β at 4h, 8h and 24h, at 24h for S25-7, and at 8h for TAP1, thus, the results 
demonstrate the concentration of Vibrogen 2 is generally proportional to the expression of these 
genes.  At 24h post-stimulation the expression of TAP1 in RTS11 cells was consistent across 
both the 1 in 100 and 1 in 500 Vibrogen 2 treatments and appeared to reach a maximum (Figure 
2-2).  This is suggested by the limited increase in expression observed between 8h and 24h for 
the 1 in 100 Vibrogen 2 stimulated cells and the increase in expression of TAP1 from 8h to 24h 
in 1 in 500 Vibrogen 2 stimulated cells combined with the observed grouping of TAP1 
normalized ratios for cells from both stimulation groups at 24h.  Further, the difference in 
normalized ratio values between the four genes is demonstrated by Figure 2-2.  IL-1β normalized 
ratios range from about three in control cells to over 800 in 1 in 100 Vibrogen 2 stimulated cells, 
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IFNγ normalized ratios range only from about 0.1 in control cell samples to approximately 0.9 in 
1 in 100 Vibrogen 2 stimulated cells, S25-7 normalized ratios ranging from about 0.1 in control 
cells to around 0.8 in 1 in 500 Vibrogen 2 stimulated cells is clearly illustrated and TAP1 
normalized ratios range from about four in control cells to approximately 25 in 1 in 100 
Vibrogen 2 stimulated cells (Figure 2-2
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Figure 2-2: IL-1β, IFNγ, S25-7 and TAP1 normalized ratios in RTS11 cells. Normalized 
ratio of each RTS11 replicate well for control wells and wells stimulated with Vibrogen 2 diluted 
in culture media to 1 in 100 or 1 in 500 at 4h, 8h and 24h obtained using the Roche LightCycler 
480 and calculated using the advanced relative quantification method are illustrated graphically 
to demonstrate variability of gene expression from well to well and gene expression trends over 
time where A illustrates normalized ratios for the IL-1β gene, B illustrates normalized ratios for 
the IFNγ gene, C illustrates normalized ratios for the S25-7 gene and D illustrates normalized 
ratios for the TAP1 gene.  The qPCR reactions were all performed in triplicate and normalized 




2.3.3 The First 24h of IL-1β, IFNγ, S25-7 and TAP1 Gene Expression in 
RTS11 Cells Stimulated with Vibrogen 2 Expressed as Fold-Change 
The normalized ratios obtained by relative qPCR for the immune relevant genes, IL-1β, 
IFNγ, S25-7, and TAP1, in RTS11 cells stimulated with Vibrogen 2, diluted in culture media to 1 
in 100 or 1 in 500 were used to determine the fold-change in expression of each gene.  The 
normalized ratios of control samples for each gene were normalized to one and the expression of 
each gene under each treatment condition and at each time point was calculated relative to its 
respective normalized control (Figure 2-3).  It was then determined by two-way ANOVA 
analysis followed by Tukey’s multiple comparisons test that significant differences between 
unstimulated control cells and stimulated cells exist for IL-1β, S25-7 and TAP1 but not IFNγ.  At 
all three time points the fold-change expression of IL-1β was significantly different between 
control RTS11 cells and both the 1 in 100 and 1 in 500 Vibrogen 2 stimulated cells (Figure 2-3).   
The p-value for all IL-1β versus control comparisons is <0.0001 except the 8h control cells 
versus 8h cells stimulated with 1 in 500 Vibrogen 2 which has a p-value of <0.0006.  For S25-7 
fold-change expression in RTS11 control cells versus cells stimulated with 1 in 100 or 1 in 500 
Vibrogen 2 a significant difference between the 8h control cells and 1 in 100 Vibrogen 2 
stimulated cells with a p-value of 0.0058 is reported while the difference in fold-change 
expression of S25-7 at 24h is extremely significant and control RTS11 cells versus both the 1 in 
100 and 1 in 500 Vibrogen 2 stimulated cells reflect a p-value of <0.0001 (Figure 2-3).  At 4h 
post-stimulation the fold-change expression of TAP1 when control RTS11 cells are compared to 
the 1 in 100 Vibrogen 2 stimulated cells is significantly different and has a p-value of 0.0422 
while at both 8h and 24h the fold-change expression of TAP1 in cells stimulated with either 1 in 
100 or 1 in 500 Vibrogen 2 versus control cells is significantly different and each comparison has 
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a p-value of <0.0001 (Figure 2-3).  In addition to significant differences observed between 
control cells and stimulated cells significant differences between 1 in 100 Vibrogen 2 and 1 in 
500 Vibrogen 2 stimulated cells exist for IL-1β, S25-7 and TAP1 (Figure 2-3).  At all three time 
points, there is a significant difference between cells stimulated with 1 in 100 Vibrogen 2 versus 
1 in 500 Vibrogen 2 for IL-1β (p-value <0.0001), while a significant difference between cells 
stimulated with 1 in 100 Vibrogen 2 versus 1 in 500 Vibrogen 2 is observed only at 24h for S25-
7 (p-value <0.0001) and only at 8h for TAP1 (p-value <0.0001) (Figure 2-3).  Additionally, the 
interaction between treatment and time is considered extremely significant (p-value <0.0001) and 
the effect of time (p-value <0.0001) and the effect of treatment (p-value <0.0001) are extremely 
significant for IL-1β, S25-7 and TAP1.  However, there is no significant interaction between 
treatment and time (p-value 0.7464) nor is the effect of treatment (p-value 0.9012) or time (p-
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Figure 2-3: IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in RTS11 cells 
following vaccination compared to control expression levels.  Fold-change expression, 
calculated from normalized ratios obtained by relative qPCR, of IL-1β, IFNγ, S25-7 and TAP1 
genes in RTS11 cells at 4h, 8h and 24h post stimulation with Vibrogen 2 diluted in culture media 
to 1 in 100 or 1 in 500 compared to unstimulated controls, where A illustrates fold-change in 
expression of the IL-1β gene, B illustrates fold-change in expression of the IFNγ gene, C 
illustrates fold-change in expression of the S25-7 gene and D illustrates fold-change in 
expression of the TAP1 gene.  The qPCR reactions were performed in triplicate and normalized 
against EF1α expression.  Control results were normalized to one and treatment groups were 
compared to control to determine fold-change expression.  Analysis by two-way ANOVA 
followed by Tukey’s multiple comparisons test was used to determine if significant differences 
between controls and treatments or between treatments at each time point exist.  Results are 
shown as mean ± SEM, n=3. 
 
Further analysis by two-way ANOVA followed by Tukey’s multiple comparisons test 
shows significant differences in fold-change gene expression between time points within a 
treatment exist for IL-1β, S25-7 and TAP1 but not IFNγ (Figure 2-4).  The fold-change 
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expression of IL-1β in 1 in 100 Vibrogen 2 stimulated cells at 8h and 24h is significantly 
different than fold-change expression at 4h (p-value <0.0001, <0.0001) and fold-change 
expression at 24h is significantly different than fold-change expression at 8h (p-value 0.0001) 
(Figure 2-4).  For the 1 in 500 Vibrogen 2 stimulated cells there is only a significant difference in 
fold-change expression of IL-1β at 24h post-stimulation compared to fold-change expression at 
4h (p-value<0.0002) (Figure 2-4).  For S25-7 significant differences between 4h and 8h, 4h and 
24h and 24h and 8h are observed for both the 1 in 100 stimulated cells and the 1 in 500 
stimulated cells (Figure 2-4).  The p-values for the 1 in 100 Vibrogen 2 stimulation group are 
0.0058, <0.0001 and <0.0001 respectively while the p-values for the 1 in 500 Vibrogen 2 
stimulation group are 0.0066, <0.0001 and <0.0001 respectively.  RTS11 cells stimulated with 1 
in 100 Vibrogen 2 or 1 in 500 Vibrogen 2, after 8h and 24h have significantly higher TAP1 gene 
fold-change expression than 4h cells (p-value <0.0001, <0.0001) and cells stimulated with 1 in 
100 Vibrogen 2 and 1 in 500 Vibrogen 2 after 24h have significantly higher TAP1 fold-change 








1 0 0 0
IL -1 β















1  in  1 0 0
1  in  5 0 0
* * * *
* * * * * * *
* * *




















1  in  1 0 0
1  in  5 0 0




S 2 5 -7















1  in  1 0 0
1  in  5 0 0
* * * *
* * * * * * * * * *
* * * * * *
4 8 2 4 4 8 2 4
1
1 0
T A P 1















1  in  1 0 0
1  in  5 0 0
* * * *
* * * *
* * * *




Figure 2-4: IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in RTS11 cells at 4h, 
8h and 24h. Comparison of fold-change gene expression, calculated from normalized ratios 
obtained by relative qPCR, of IL-1β, IFNγ, S25-7 and TAP1 in RTS11 cells at 4h, 8h and 24h 
post stimulation with Vibrogen 2 diluted in culture media to either 1 in 100 or 1 in 500, where A 
illustrates fold change in expression of the IL-1β gene, B illustrates fold-change in expression of 
the IFNγ gene, C illustrates fold-change in expression of the S25-7 gene and D illustrates fold-
change in expression of the TAP1 gene.  The qPCR reactions were performed in triplicate and 
normalized against EF1α expression.  Control results were normalized to one and treatment 
groups were compared to control to determine fold-change expression.  Analysis by two-way 
ANOVA followed by Tukey’s multiple comparisons test was used to determine if significant 
differences between 1 in 100 Vibrogen 2 and 1 in 500 Vibrogen 2 stimulated RTS11 cells across 
time points.  Results are shown as mean ± SEM, n=3. 
 
Comparison of the fold-change gene expression of IL-1β, IFNγ, S25-7 and TAP1 in cells 
stimulated with 1 in 100 or 1 in 500 Vibrogen 2 demonstrates the differential expression of these 
four immune relevant genes (Figure 2-5).  Of the four genes IL-1β consistently has the highest 
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level of fold-change expression across time points while IFNγ has the lowest level of fold-
change gene expression across time points for cells stimulated with either 1 in 100 Vibrogen 2 or 
1 in 500 Vibrogen 2 (Figure 2-5).  The only gene with significantly different fold-change gene 
expression compared to the fold-change gene expression of the remaining three genes is IL-1β 
(p-value <0.0001) (Figure 2-5).   This difference is observed across time points for both 1 in 100 
Vibrogen 2 and 1 in 500 Vibrogen 2 stimulated cells.  There is no significant difference between 
the fold-change gene expression of IFNγ, S25-7 and TAP1 for cells stimulated with either 1 in 
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Figure 2-5: Summary of IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in 
RTS11 cells.  Fold-change gene expression, calculated from normalized ratios obtained by 
relative qPCR, of IL-1β, IFNγ, S25-7 and TAP1 for RTS11 cells stimulated with 1 in 100 
Vibrogen 2 or 1 in 500 Vibrogen 2 prepared in cell media, for comparison of fold-change 
expression levels between different genes where A illustrates 1 in 100 Vibrogen 2 stimulated 
cells and B illustrates 1 in 500 Vibrogen 2 stimulated cells. The qPCR reactions were performed 
in triplicate and normalized against EF1α expression.  Control results were normalized to one 
and treatment groups were compared to control to determine fold-change expression.  Analysis 
by two-way ANOVA followed by Tukey’s multiple comparisons test was used to determine if 
significant differences between genes over time exist.  Results are shown as mean ± SEM, n=3.  
54 
 
2.4  Discussion 
The RTS11 cell line is a combination of two cell types, and while there are a small number 
of adherent macrophage-like cells the majority of cells are small, round monocyte-like cells 
(Ganassin & Bols, 1998).  The qualitative observations presented in Figure 2-1 provide limited 
support to suggest RTS11 cells undergo morphological changes and differentiation of monocyte-
like cells to mature macrophage-like cells due to stimulation with Vibrogen 2.  It is possible that 
the vaccine is stimulating the differentiation of immature monocytes into mature macrophage-
like cells however, these results are inconclusive and further work is necessary to better 
understand the process involving changes in cell morphology and differentiation of RTS11 cells 
after Vibrogen 2 stimulation.  It does appear clear from the results that the vaccine does not have 
a significant impact on cell number, that is, cells are neither stimulated to proliferate nor do they 
undergo cell death after Vibrogen 2 stimulation at these doses, as there was no significant 
difference between the number of cells in control wells versus stimulated wells at 72h post 
stimulation and there were no observed cytopathic effects (Figure 2-1).  This ensures that 
differences in gene expression observed between control and stimulated cells within a time point 
are not affected by the number of cells tested.  While it is unclear what effect Vibrogen 2 has on 
the physical characteristics of RTS11 cells it is possible to understand what is occurring within 
the cell after Vibrogen 2 stimulation through RT relative qPCR assays. 
Previously, Martin, Zou, Houlihan, & Secombes, (2007) demonstrated that RTS11 cells 
exposed to rIL-1β up-regulated genes involved in the pro-inflammatory response, while RTS11 
cells, exposed to rIFNγ up-regulated genes associated with antigen presentation.  The goal of this 
study was to understand the immune response triggered, in rainbow trout RTS11 cells, by the 
commercially available vaccine, Vibrogen 2.  It was expected that, in RTS11 cells, IL-1β would 
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be transiently up-regulated followed by up-regulation of IFNγ which would lead to initiation of 
the adaptive immune response including up-regulation of MH class II associated genes, such as 
S25-7 but not MH class I associated genes, such as TAP1.  In contrast to expected results, IL-1β 
was significantly up-regulated, in response to both 1 in 100 and 1 in 500 Vibrogen 2, at 4h and 
the level of gene expression continued to increase through 8h and 24h and did not return to basal 
levels (Figures 2-2, 2-3 and 2-4).  It is difficult to predict the reason IL-1β does not return to 
basal levels and why the level of expression continues to increase, in RTS11 cells following 
Vibrogen 2 stimulation, without further investigation of the regulation of IL-1β antagonist genes 
such as interleukin-1F (IL-1F) or pro-inflammatory regulatory genes such as the potent anti-
inflammatory cytokine IL-10 (Piazzon, Lutfalla, and Forlenza, 2016; Wang et al., 2009; Zou & 
Secombes, 2016).  However, in a previous study Castro, Zou, Secombes, & Martin, (2011) 
demonstrated the up-regulation of IL-10 in response to cortisol in RTS11 and it is well 
understood that mammalian macrophages, when activated via the classical pathway, secrete high 
levels of IL-12 but only modest levels of IL-10  (Mosser, and Edwards, 2008).  Thus, RTS11 
cells may up-regulate the IL-10 gene in response to Vibrogen 2 but the level of protein 
expression may be too low to create the necessary negative feedback message to bring IL-1β 
expression back to basal levels.  Further, in mammals IL-10 is responsible for a range of 
activities including inhibiting pro-inflammatory cytokine expression and MHC class II 
expression, as well as, stimulating B-cells and the secretion of antibodies and the anti-
inflammatory pathway is only activated after the IL-10 receptor complex (IL10R), formed by IL-
10 binding two IL-10 receptor 1 (IL10R1) molecules and two IL-10 receptor 2 (IL10R2) 
molecules, is activated (Piazzon, Lutfalla, and Forlenza, 2016).  Therefore, expression of IL-10 
alone may not be sufficient to turn off IL-1β gene expression and other proteins that are not 
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present may be required to initiate the anti-inflammatory pathway and turn off IL-1β gene 
expression.  Another possible reasons IL-1β is expressed at high levels could be that it is 
necessary to dramatically increase IL-1β gene expression as the gene is not constitutively 
expressed and the gene expression levels are zero or near zero in control cells (Figure 2-2).  
Further, this high level of expression may be required to produce sufficient IL-1β protein in the 
required time frame to initiate an appropriate immune response and a 24h period may not be 
sufficient for this high level of expression to receive the necessary signals to lower expression 
and finally return to basal levels (Figure 2-2).  Another consideration is that additional cell types, 
not part of the RTS11 cell line, are required to complete the feedback loops necessary for down-
regulation of IL-1β gene expression.  
The results also show that IFNγ gene expression is not significantly up-regulated despite the 
high level of IL-1β gene expression however, it does appear that the expression of S25-7, one of 
the MH class II associated invariant chain genes, is significantly up-regulated in response to 1 in 
100 Vibrogen 2 at 8h and in response to both 1 in 100 and 1 in 500 Vibrogen 2 stimulation at 
24h (Figures 2-2 and 2-3).  Interestingly, the MH class I associated gene, TAP1, was also 
significantly up-regulated at 4h in 1 in 100 Vibrogen 2 stimulated RTS11 cells and in response to 
both 1 in 100 and 1 in 500 Vibrogen 2 at 8h and 24h (Figures 2-2 and 2-3).  While the results for 
IL-1β, IFNγ and TAP1 are contrary to those expected the expression of S25-7 does appear to 
follow the anticipated trend and expression is increasing over time suggesting up-regulation of 
MH class II.  In mammals, it is well established that MHC class II is required for production of 
an effective antibody response and plays an important role in T-cell/B-cell collaboration as well 
as thymocyte education, therefore, evidence of MH class II up-regulation suggests that the 
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Vibrogen 2 vaccine is leading to the stimulation of an adaptive immune response in RTS11 cells 
which may lead to antibody production (Cosgrove et al., 1991).  
The up-regulation of S25-7, along with the results of Martin et al., (2007), that demonstrate 
TAP1 expression in RTS11 cells is up-regulated at 24h by rIFNγ, but not rIL-1β, provide 
evidence that although IFNγ gene expression does not appear to be up-regulated in RTS11 cells 
after stimulation with Vibrogen 2, the expression of IFNγ protein may be up-regulated which in 
turn leads to up-regulation of genes involved in antigen presentation.  The lack of significant 
difference in IFNγ gene expression may reflect the need to closely regulate the immune response 
to ensure proper control and limit unnecessary damage caused by over expression of IFNγ or it 
could simply reflect the fact that the basal level of IFNγ gene expression is maintained at the 
level required for an effective immune response to avoid any delay in producing sufficient 
protein for an appropriate immune response.  Another consideration is that the IFNγ gene was 
transiently up-regulated and the time-point at which the expression of this gene occurred was not 
investigated or perhaps, given that RTS11 is a mixed culture of primarily immature monocyte-
like cells, the number of differentiated IFNγ producing cells may have been low and thus any 
significant increase or decrease in gene expression remained hidden.  Figure 2-4 does provide 
some evidence to support these theories given the expression of IFNγ does appear to be trending 
up over time but does not increase to significant levels.  The possibility also exists, that in 
rainbow trout macrophage cells, there is an alternate pathway for the activation of antigen 
presentation that does not involve IFNγ and this response was induced by the Vibrogen 2 
vaccine.    
It is unclear why TAP1 gene expression is up-regulated in response to Vibrogen 2 given 
MH class I is thought to be responsible for presentation of antigens that have entered a cell, such 
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as viral pathogens or intracellular bacteria (Magnadottir, 2010; Martin et al., 2007).  It is possible 
that the RTS11 cells received a higher dose of Vibrogen 2 or may have been in direct contact 
with the vaccine longer than cells typically would in vivo as they may not possess the machinery 
a fish does for processing all the bacterin components however, in a previous study Acosta et al., 
(2004) demonstrated up-regulation of the antiviral effector gene Mx, in Atlantic salmon, 
following vaccination with a V. anguillarum-V. ordalii vaccine, as well as, after injection with V, 
anguillarum LPS or DNA.  Therefore, up-regulation of TAP1 may be evidence of cross-
presentation in teleosts, either triggered by V. anguillarum or V. ordalii derived molecules such 
as nucleic acids, proteins, LPS and/or toxins or by added vaccine components.  Cross-
presentation by macrophages and DCs has been demonstrated in mammals and it has been 
suggested that exploiting this pathway could lead to more effective vaccines (Basta & Alatery, 
2007; Cruz, Colbert, Merino, Kriegsman, & Rock, 2017).  Despite evidence that suggests TAP is 
not involved in the cross-presentation pathway in mammals and that the pathway involves the 
non-classical MHC class I, HLA-F associated with MHC class I open conformers the cross-
presentation pathway in teleost may involve classical MH class I or non-classical MH class I that 
utilizes TAP1 (Goodridge et al., 2013; Grimholt, 2016).  It is also possible that in salmonids both 
MH class I and MH class II are up-regulated as part of an effective adaptive immune response or 
that MH class I is responsible for presentation of both endogenous and exogenous antigen which 
may support the loss of MH class II machinery in cod (Grimholt, 2016; Star, Nederbragt, Jentoft, 
Grimholt, Malmstrøm, Gregers, Rounge, Paulsen, Solbakken, Sharma, Wetten, Lanzén, Winer, 
Knight, Vogel, Aken, Andersen, Lagesen, & Tooming-Klun, 2011).  However, it is also possible 
that MH class I associated genes are up-regulated solely in preparation for mounting a response 
in the event one is necessary but do not go on to present antigen.  
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The results of this study also indicate that dose may play an important role in the strength of 
immune response triggered.  While the difference in expression is not always significant, when 
the expression of IL-1β, S25-7 and TAP1 in response to a 1 in 100 dilution versus a 1 in 500 
dilution of Vibrogen 2 are compared, a higher concentration of vaccine correlates with a higher 
level of expression except for at 24h for TAP1 gene expression, where both treatments stimulate 
the same level of gene expression (Figure 2-4).  This would suggest that correct and accurate 
dosing is necessary to stimulate an appropriate immune response and that overdose could lead to 
serious side effects that may even be fatal as inflammation, which leads to tissue damage, when 
not carefully controlled can cause irreparable damage and over expression of regulatory 
cytokines can lead to dangerous over expression of immunological pathways leading to increased 
morbidity and mortality (Bystrom et al., 2008; Rieger et al., 2012; Teijaro, Walsh, Rice, Rosen, 
& Oldstone, 2014). 
Overall, these results show IL-1β gene expression is significantly up-regulated in 
comparison to IFNγ, S25-7, and TAP1 at all time points for RTS11 cells treated with either 1 in 
100 or 1 in 500 Vibrogen 2 (Figure 2-5).  While, the expression of TAP1 generally trends higher 
than S25-7, except at 24h in the 1 in 500 Vibrogen 2 stimulated cells, and both TAP1 and S25-7 
gene expression trend higher than IFNγ gene expression, there is no significant difference 
between the expression of these three genes (Figure 2-5).  Thus, it appears that the Vibrogen 2 
vaccine has a dramatic effect on the expression of IL-1β but the effect on downstream gene 
expression, although significant when compared to control cells for S25-7 and TAP1, is far less 
impressive (Figures 2-2 and 2-5).  This may suggest that although the vaccine is stimulating the 
MH class II pathway, demonstrated by the significant up-regulation of S25-7, the vaccine may be 
preferentially driving a pro-inflammatory response (Figures 2-2 and 2-5).   However, it may also 
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be possible that S25-7 gene expression will increase at later time points.  The expression of the 
TAP1 gene may also reach peak levels at a later time point and the increased expression of this 
gene raises many questions regarding the role of the MH class I pathway in rainbow trout long 
term immunity.   Certainly, the results presented here provide strong evidence that Vibrogen 2 is 
not only responsible for macrophage activation but also up-regulation of MH class II associated 
genes, as well as, the MH class I associated genes suggesting MH class I may play a role in both 
endogenous and exogenous antigen presentation in rainbow trout.  Therefore, it may be 
important to consider both MH class I and MH class II presentation pathways when developing 
vaccines for use in aquaculture and exploiting cross-presentation may lead to more effective 














Induction of IL-1β, IFNγ, S25-7 and TAP1 in Rainbow Trout Head 
Kidney by the Vibrogen 2 Vaccine 
 
3.1  Introduction 
The rainbow trout is a member of the Salmonidae family and while the species is native 
to the Pacific coast of North America and Russia, it has been introduced around the world to 
areas with cooler water temperatures and is a popular food and sport fish (Thorgaard et al., 
2002).  A breadth of basic biological knowledge has been collected about the rainbow trout and 
the rainbow trout can serve as a proxy for other salmonid species including Atlantic salmon, 
Pacific salmon and charr (Thorgaard et al., 2002).  Additionally, rainbow trout have a larger size 
relative to other common fish models and are generally more amenable to surgery than smaller 
species and their larger size also permits collection of larger tissue samples and isolation of a 
greater number of cells for biochemical, immunological and molecular biological testing 
(Thorgaard et al., 2002).  Thus, rainbow trout are an important model organism and have been 
widely studied in a diverse range of research areas (Thorgaard et al., 2002). 
Immunological studies of rainbow trout not only provide data for comparison of the 
human and salmonid immune system for biomedical and evolutionary studies but also provide 
data relevant and of immediate importance to the aquaculture industry (Thorgaard et al., 2002).  
The primary immune organ in rainbow trout is the head kidney which is a haematopoietic organ 
morphologically similar to mammalian bone marrow (Press & Evensen, 1999; Soulliere & 
Dixon, 2017).  It is believed that the stroma of the head kidney, in addition to providing support 
to the haematopoietic tissue, is involved in non-specific immunity and clearing cell debris as 
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well as damaged cells (Press & Evensen, 1999).  Additionally, it has been demonstrated that 70 
percent of injected radiolabeled bacteria localize to the head kidney where sinusoidal 
macrophages and endothelial cells are involved in capturing substances and debris from the 
blood (Press & Evensen, 1999).  Furthermore, the head kidney is responsible for production and 
maturation of B cells, as well as, progenitor T cells (Soulliere & Dixon, 2017).  It has also been 
suggested that the head kidney acts as a secondary lymphoid organ and may be involved in 
antibody production  (Press & Evensen, 1999; Soulliere & Dixon, 2017).   A handful of 
immunological studies investigating the gene expression of pro-inflammatory cytokines in 
rainbow trout head kidney and/or primary head kidney leukocytes, as well as, the gene 
expression of MH class I and MH class I accessory proteins and the gene expression of MH class 
II and MH class II accessory proteins, including S25-7, have been described previously (Chettri 
et al., 2011; Christie, 2007; Fujiki et al., 2003; Jørgensen, Hetland, Press, Grimholt, & Gjøen, 
2007; Sever, Vo, Bols, et al., 2014; Sever, Vo, Lumsden, et al., 2014).  The aim of this study is 
to understand the innate/adaptive immune response interface in rainbow trout head kidney in 
response to vaccination with Vibrogen 2, to reveal the immunological response triggered in 
rainbow trout following vaccination and to better understand the immune response of fish.  
Given the success of this vaccine in comparison to other commercially available vaccines it is 
important to understand the immune response triggered in vaccinated fish, as this may be useful 
for production of effective vaccines to additional pathogens.  It is hypothesized that after 
stimulation with Vibrogen 2, the pro-inflammatory cytokine IL-1β transcript will be transiently 
up-regulated in head kidney leading to up-regulation of the IFNγ gene, a key cytokine of the 
adaptive immune response, in the head kidney.  This will be followed by up-regulation of the 
63 
 
S25-7 gene, an MH class II associated invariant chain but not TAP1, an MH class I associated 
transporter protein, in rainbow trout head kidney. 
3.2  Materials and Methods 
3.2.1  Rainbow Trout Transport 
Sexually immature rainbow trout weighing approximately 190 to 200 grams were 
obtained from Alma Aquaculture Research Station (AARS) (University of Guelph).  
Approximately 360 rainbow trout were transported by AARS staff in an oxygenated tank from 
AARS to the University of Waterloo aquatics facility.  Upon arrival, all 360 fish were transferred 
to an outdoor holding tank by net.  Of these 260 fish were transferred, using fish nets, to a 450-
gallon holding tank for future trials and 100 fish were equally distributed at random into four 
180-gallon treatment tanks; Tank 1, Tank 2, Tank 3 and Tank 4, in Biology 1 (B1) room 377B 
(Figure 3-1).  
3.2.2 In vivo Rainbow Trout Trials 
The photoperiod in B1-177B was 18h light to 6h dark and fish were acclimated for four 
and a half weeks prior to the start of the trial.  Each tank was checked daily and fish were fed 
three-point floating trout chow (Martin Mills) to satiation once daily Monday to Friday and were 
not fed on Saturday and Sunday.  At the time of the trial trout in all tanks had been feeding well 
and appeared to be in good health.   
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Figure 3-1: Aquatic facility trial room.  Photo of Biology 1 room 377B treatment room tank 
set up 
 
Beginning three days before the trial feed was withheld. On day one, each tank was 
assigned a treatment according to Table 3-2.  Control fish were not treated or handled at the time 
of injection.  Saline control or “sham injected” and Vibrogen 2 (Novartus) treated fish were 
anesthetized in an anesthetic bath containing 25-40mL of Benzocaine, prepared by 
Table 3-2: Treatments in each tank for each in vivo trial 














NA-Treatment group was used for a second study not described here 
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dissolving 50g of ethyl 4-aminobenzoate in 500mL of anhydrous ethanol, and received an i.p. 
injection of 100µl of DPBS or Vibrogen 2 respectively (Figure 3-2).  Two different individuals 
carried out i.p injections simultaneously with a 25-gauge needle and 1mL syringe.  Immediately 
following injection fish were transferred to a recovery bath, one per treatment, supplied with 
oxygen. After the last fish was injected all fish in that treatment group were returned to the 

















Figure 3-2: In vivo trial sampling. Photo panel of sampling steps showing anesthetizing, 




One hour after all fish were returned to their respective treatment tank and at 4h, 8h, 12h, 
24h and 48h three fish from each tank were collected and anesthetized as described above 
(Figure 3-2).  Blood was drawn from the caudal blood sinus with a 25-gauge heparinized needle 
and 10ml syringe until exsanguination (Figure 3-2).  Blood was then transferred to 15ml conical 
tubes and placed on ice for transport and subsequent peripheral blood leukocyte (PBL) extraction 
and plasma collection.  The fish were euthanized in a Benzocaine bath and then placed on ice.  
Weight and length were recorded and head kidney, spleen and muscle tissue was collected from 
each fish (Figure 3-2).  The gender of the fish was recorded when possible and any unusual 
markings and signs of infection or poor health were noted.  Tissues were dissected, placed in 
labeled 5ml Eppendorf tubes and immediately flash frozen by immersion in liquid nitrogen 
(Figure 3-2).  Once frozen tubes containing tissue were transferred to dry ice and transported to a 
-80oC freezer for storage until processing.   
The trial was repeated and all steps were carried out as describe above except each tank 
was assigned a different treatment (Table 3-2).  Additionally, for the second trial 100 rainbow 
trout from holding were moved by net and evenly distributed between the four treatment tanks in 
B1-177B.  Fish were acclimated for two and a half weeks before the start of the trial. This trial 
was conducted seven and a half weeks from the start of the first trial. 
3.2.3  Ribonucleic Acid and Protein Extraction 
RNA and protein were extracted from tissue samples using the Norgen RNA and Protein 
Plus purification kit according to the manufacturers’ specifications.  In brief, 25µg of tissue was 
homogenized in lysis buffer.  gDNA was removed, RNA was purified and the flow through 
containing the protein extract was retained as described above for RTS11 cells. 
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3.2.4  Ribonucleic Acid Quantification and Purity and cDNA Synthesis 
 RNA purity and quantification of each RNA sample was determined as described above.   
cDNA was prepared using the Maxima H Minus First Strand cDNA Synthesis Kit, with dsDNase 
(Thermo Fisher Scientific) as described above for all samples except S8C.  Quantification of 
sample S8C RNA indicated that the RNA concentration was 114.4ng/µl therefore the cDNA 
reaction volume was adjusted to ensure that 1μg of total RNA was added.    For this reaction 
2.18µl dsDNase mix was added and nuclease free water was excluded as 8.74μl of RNA sample 
were required to obtain the necessary 1μg of RNA. Thus, the dsDNase reaction volume was 
10.92µl.  After completing the dsDNase step, random hexamer primer and dNTP mix plus water 
were added bringing the reaction volume to 16.38µl and the optional GC rich incubation step 
was performed.  Lastly, the RT reagents were added bringing the final reaction volume to 
21.84µl and cDNA synthesis was completed as previously outlined.  All samples were stored at -
80oC for future use. 
3.2.5  Quantitative Polymerase Chain Reaction 
All head kidney cDNA samples, except S8C, were handled as described above.  As the final 
reaction volume of sample S8C was modified to account for the lower RNA concentration of this 
sample, it was necessary to modify the SYBR reaction. In summary, the volume of nuclease free 
PCR-grade water was reduced to 1.41μl and the volume of cDNA template was increased to 
1.09μl, while all other reagent volumes were added as outlined above.  The final reaction volume 
for all samples was 10μl and the qPCR protocol was performed as described above for RTS11 




3.2.6  Analysis 
All analysis’ were performed as described above.  
3.3  Results 
3.3.1  Size of Rainbow Trout 
After sacrifice, each rainbow trout was weighed and length was recorded.  These values 
were used to determine if the size of fish varied from treatment to treatment or from sample time 
point to sample time point.  Two-way ANOVA analysis followed by Tukey’s multiple 
comparisons test shows that no significant difference between treatment or time points was 
observed for fish weight or fish length (Appendix B). 
3.3.2 Normalized Ratios of IL-1β, IFNγ, S25-7 and TAP1 in Head Kidney of                 
Rainbow Trout Stimulated with Vibrogen 2 Demonstrate Patterns in 
Gene Expression Profiles 
Relative qPCR investigating the expression of four genes: IL-1β, IFNγ, S25-7, and 
TAP1, in rainbow trout head kidney of unvaccinated control fish and fish vaccinated by i.p. 
injection with 100µl Vibrogen 2 or injected with 100µl saline, provides a normalized ratio 
representative of the expression of each gene of interest relative to the expression of the EF1α 
reference gene.  These normalized ratios when plotted graphically (Figure 3-3) demonstrate the 
variability of gene expression from fish to fish, allow for the identification of outliers and 
illustrate the gene expression trends for each gene over time.  In Figure 3-3, the normalized ratios 
for IL-1β demonstrate that the expression of this gene is not upregulated in the head kidney of 
saline injected fish or fish from the control group and the saline injected group and control group 
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cluster together across all time points.  In contrast, expression of IL-1β is upregulated in fish 
injected with Vibrogen 2 at 4h and 8h but not at 24h (Figure 3-3).  At 4h all three fish injected 
with Vibrogen 2 differentially upregulate the expression of IL-1β in the head kidney while two 
of the three fish injected with Vibrogen 2 upregulated the expression of IL-1β in head kidney at 
8h (Figure 3-3).   Thus, Figure 3-3 clearly demonstrates that the up-regulation of IL-1β varies 
from fish to fish.  Additionally, it appears that at 4h IL-1β reaches higher levels of expression in 
the head kidney of Vibrogen 2 injected fish, than it does at 8h, and by 24h the expression of IL-
1β in the head kidney of Vibrogen 2 injected fish returns to control levels (Figure 3-3).  The 
expression patterns of IFNγ are less clearly defined than those demonstrated for IL-1β however, 
it appears that at 4h the normalized ratio for each fish in all three groups; control, saline injected 
and Vibrogen 2 injected, cluster together (Figure 3-3).  At 8h it appears that there is a high level 
of fish to fish variability in head kidney IFNγ expression and while the IFNγ normalized ratios of 
saline injected fish appear to cluster together the normalized ratios from control fish and 
Vibrogen 2 injected fish do not (Figure 3-3).  By 24h the normalized ratios of fish injected with 
Vibrogen 2 group together above the saline injected and control normalized ratios except for one 
outlier, a saline injected fish with a normalized ratio above the normalized ratios of all other fish 
(Figure 3-3).  Like IFNγ the expression trends of S25-7 in head kidney are difficult to discern.  
While the normalized ratios of control, saline injected and Vibrogen 2 vaccinated fish cluster 
together at 8h and 24h at 4h they are spread across a range of normalized ratios however, at 4h 
one fish from each group has a normalized ratio above any ratio found at either 8h or 24h and the 
fish with the highest normalized ratio belongs to the Vibrogen 2 stimulated group (Figure 3-3).  
For TAP1 the normalized ratios of fish from all three treatment groups cluster together at 4h and 
8h however at 4h two control fish group together above the larger cluster (Figure 3-3).  At 24h 
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there are two distinct clusters, the lowest represents the normalized ratios of control fish while 
the second slightly higher cluster represents saline injected fish and the normalized ratios of 
Vibrogen 2 injected fish are found above this cluster (Figure 3-3).  The fish to fish variability 
that was clearly observed for IL-1β up-regulation is also observed for TAP1 and the results for 
IFNγ and S25-7 also suggest that the regulation of these genes varies from fish to fish (Figure 3-
3).  Further, the difference in normalized ratio values between the four genes is demonstrated by 
Figure 3-3.  IL-1β normalized ratios range from about zero in control fish head kidney to over 22 
in Vibrogen 2 vaccinated fish head kidney, IFNγ normalized ratios range only from about 0.1 in 
control head kidney samples to approximately 1.8 in Vibrogen 2 vaccinated fish head kidney, 
S25-7 normalized ratios ranging from about 0.4 in control fish head kidney to around 1.7 in 
Vibrogen 2 vaccinated fish head kidney were observed and TAP1 normalized ratios range from 
about 0.4 in control fish head kidney to approximately 2.4 in Vibrogen 2 vaccinated fish head 
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Figure 3-3: IL-1β, IFNγ, S25-7 and TAP1 normalized ratios in head kidney. Normalized 
ratio, obtained by relative qPCR, of each rainbow trout head kidney for control fish and fish 
vaccinated by i.p. injection with 100µl Vibrogen 2 or 100µl saline at 4h, 8h and 24h obtained 
using the Roche LightCycler 480 and calculated using the advanced relative quantification 
method are illustrated graphically to demonstrate variability of gene expression from fish to fish 
and gene expression trends over time where A illustrates normalized ratios for the IL-1β gene, B 
illustrates normalized ratios for the IFNγ gene, C illustrates normalized ratios for the S25-7 gene 
and D illustrates normalized ratios for the TAP1 gene.  The qPCR reactions were performed in 
triplicate and normalized against EF1α expression. 
 
3.3.3 The First 24h of IL-1β, IFNγ, S25-7 and TAP1 Gene Expression in the 
Head Kidney of Rainbow Trout Vaccinated with Vibrogen 2 Expressed 
as Fold-Change 
The normalized ratios obtained by relative qPCR for the four genes of interest, IL-1β, IFNγ, S25-
7, and TAP1, for rainbow trout head kidney from fish i.p. injected with saline, or vaccinated with 
72 
 
Vibrogen 2 were used to determine the fold-change expression of each gene.  For each gene, the 
normalized ratios of control fish were normalized to one and the expression of each gene under 
each treatment condition and at each time point was calculated relative to the respective 
normalized control (Figure 3-4).  It was determined by two-way ANOVA analysis followed by 
Tukey’s multiple comparisons test that significant differences in fold-change gene expression 
between control fish and Vibrogen 2 vaccinated fish exist for IL-1β, IFNγ and TAP1 but not 
S25-7.  At 4h the fold-change expression of IL-1β in head kidney was significantly different 
between control fish and Vibrogen 2 vaccinated fish (p-value <0.0001) (Figure 3-4).  For IFNγ 
expression in head kidney from control fish versus head kidney from fish vaccinated with 
Vibrogen 2, a significant difference between the 24h control fish and Vibrogen 2 vaccinated fish 
with a p-value of 0.0383 is reported (Figure 3-4).   At 24h post-vaccination the expression of 
TAP1 when control fish head kidney fold-change expression is compared to the Vibrogen 2 
vaccinated fish head kidney fold-change expression, is significantly different and has a p-value 
of 0.0176.  In addition to significant differences observed between control fish and Vibrogen 2 
vaccinated fish significant differences in fold-change gene expression of saline injected fish and 
Vibrogen 2 vaccinated fish exist for IL-1β and TAP1 (Figure 3-4).  At 4h there is a significant 
difference in fold-change gene expression between head kidney from Vibrogen 2 vaccinated fish 
versus head kidney from saline injected fish for IL-1β expression (p-value <0.0001), and a 
significant difference between head kidney from Vibrogen 2 vaccinated fish versus head kidney 
from saline injected fish at 24h for TAP1 expression (p-value 0.0005) (Figure 3-4).  
Additionally, for IL-1β fold-change expression in head kidney the interaction between treatment 
and time is considered extremely significant (p-value 0.0002) and the effect of treatment (p-value 
0.0001) is extremely significant while the and the effect of time (p-value 0.0010) is very 
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significant.   The interaction between treatment and time is not quite significant (p-value 0.0609) 
as is the effect of treatment (p-value 0.0692) however the effect of time (p-value 0.0028) is 
extremely significant for IFNγ expression in head kidney.  For S25-7 expression in head kidney, 
the interaction between treatment and time is considered not significant (p-value 0.3828) as is the 
effect of treatment (p-value 0.7194) and the effect of time is not quite significant (p-value 
0.0783).  The interaction between treatment and time is very significant (p-value 0.0025) and the 
effect of treatment (p-value 0.0002) and time (p-value 0.0006) are both considered extremely 
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Figure 3-4: IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in head kidney 
following vaccination compared to control expression levels. Fold-change expression, 
calculated from normalized ratios obtained by relative qPCR, of IL-1β, IFNγ, S25-7 and TAP1 
genes in rainbow trout head kidney at 4h, 8h and 24h post-stimulation with 100µl i.p. injected 
saline or 100µl i.p. injected Vibrogen 2 compared to unvaccinated controls, where A illustrates 
fold-change in expression of the IL-1β gene, B illustrates fold-change in expression of the IFNγ 
gene, C illustrates fold-change in expression of the S25-7 gene and D illustrates fold-change in 
expression of the TAP1 gene.  The qPCR reactions were performed in triplicate and normalized 
against EF1α expression.  Control results were normalized to one and treatment groups were 
compared to control to determine fold-change expression.  Analysis by two-way ANOVA 
followed by Tukey’s multiple comparisons test was used to determine if significant differences 
between controls and treatments or between treatments exist.  Results are shown as mean ± 
SEM, n=3.  
 
Further analysis by two-way ANOVA followed by Tukey’s multiple comparisons test 
show significant differences in fold-change gene expression between time points within a 
treatment exist for IL-1β, IFNγ and TAP1 but not S25-7 (Figure 3-5).  The fold-change 
expression of IL-1β in the head kidney of Vibrogen 2 vaccinated fish at 8h and 24h is 
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significantly different than fold-change expression at 4h (p-values 0.0002, <0.0001) and a 
significant difference between 4h and 24h fold-change expression is observed for IFNγ (Figure 
3-5).  In the head kidney of fish vaccinated with Vibrogen 2 after 8h and 24h TAP1 fold-change 
gene expression is significantly higher than TAP1 fold-change gene expression at 4h (p-values 
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Figure 3-5: IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in head kidney at 4h, 
8h and 24h.  Comparison of fold-change gene expression, calculated from normalized ratios 
obtained by relative qPCR, of IL-1β, IFNγ, S25-7 and TAP1 in rainbow trout head kidney at 4h, 
8h and 24h post-vaccination with Vibrogen 2, where A illustrates fold-change in expression of 
the IL-1β gene, B illustrates fold-change in expression of the IFNγ gene, C illustrates fold 
change in expression of the S25-7 gene and D illustrates fold-change in expression of the TAP1 
gene. The qPCR reactions were performed in triplicate and normalized against EF1α expression.  
Control results were normalized to one and treatment groups were compared to control to 
determine fold-change expression.  Analysis by two-way ANOVA followed by Tukey’s multiple 
comparisons test was used to determine if significant differences between time points exist.  
Results are shown as mean ± SEM, n=3.  
 
Comparison of the fold-change gene expression of IL-1β, IFNγ, S25-7 and TAP1 demonstrates 
the differential expression of these four immune relevant genes in head kidney (Figure 3-6).  Of 
the four genes IL-1β consistently has the highest fold-change expression across time points while 
IFNγ, S25-7 and TAP1 fold-change expression is more variable across time points (Figure 3-6).  
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The only gene with significantly different fold-change gene expression is IL-1β (p-value 
<0.0001) and this difference is observed only for 4h fold-change expression (Figure 3-6).  That 
is, in comparison to IL-1β fold-change expression at 8h and 24h, as well as, fold-change 
expression of all other genes across all time points the 4h fold-change expression of IL-1β is 
significantly different however there is no significant difference in fold-change IL-1β expression 
at 8h or 24h compared to IFNγ, S25-7 or TAP1 fold-change expression and there is no 




















1 0 0 0
1 0 0 0 0

















S 2 5 -7












Figure 3-6: Summary of IL-1β, IFNγ, S25-7 and TAP1 fold-change gene expression in head 
kidney.  Fold-change gene expression, calculated from normalized ratios obtained by relative 
qPCR, of IL-1β, IFNγ, S25-7 and TAP1 in head kidney of fish vaccinated with Vibrogen 2, for 
comparison of gene expression levels between different genes.  The qPCR reactions were 
performed in triplicate and normalized against EF1α expression.  Control results were 
normalized to one and treatment groups were compared to control to determine fold-change 
expression.  Analysis by two-way ANOVA followed by Tukey’s multiple comparisons test was 
used to determine if significant differences between genes over time exist.  Results are shown as 
mean ± SEM, n=3.  
 
3.4 Discussion 
It has been demonstrated that the life stage of rainbow trout effects the immune response an 
individual can mount (Magnadottir, 2010).  The results of this trial are considered unaffected by 
fish size as the weight and length of each fish was recorded and it was determined that neither 
the average weight nor length of fish was significantly different between treatment groups or 
across time points (Appendix B).  Additionally, all fish were obtained from the same source at 
the same time and were sexually immature.  Therefore, the life stage of the fish is unlikely to 
affect the results obtained.  Further, it is unlikely that the rainbow trout sampled were previously 
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exposed to either V. anguillarum or V. ordalii as they were reared in a freshwater facility.  
Therefore, these results reflect vaccination of naïve rainbow trout against V. anguillarum and V. 
ordalii by i.p injection with the commercially available Vibrogen 2 vaccine. 
In a previous study conducted by Boltana et al., (2014) expression of the IL-1β gene in the 
head kidney of gilthead seabream injected with V. anguillarum LPS was investigated and Chettri 
et al., (2011) isolated rainbow trout head kidney leukocytes and exposed them to a series of 
substances that mimic the molecular patterns of different pathogens to determine the expression 
profiles of key immune genes including important pro-inflammatory genes such as IL-1β and 
IFNγ.  While Vibrogen 2 has been licensed  for use for over 17 years an investigation of the 
immune response triggered after vaccination with this vaccine has not been conducted (Canadian 
Food Inspection Agency, 2017).  The goal of this study was to understand the immune response 
triggered, in rainbow trout head kidney, by the commercially available vaccine, Vibrogen 2.  It 
was expected that, in rainbow trout head kidney, IL-1β would be transiently up-regulated 
followed by up-regulation of IFNγ, which would lead to initiation of the adaptive immune 
response including up-regulation of MH class II associated genes such as S25-7, but not MH 
class I associated genes, such as TAP1.   
As expected, IL-1β gene expression appears to be transiently up-regulated in Vibrogen 2 
vaccinated fish while saline injected fish do not up-regulate IL-1β gene expression (Figure 3-3).  
This gene was significantly up-regulated, in Vibrogen 2 vaccinated fish, at 4h but not 8h, and by 
24h had returned to basal expression levels (Figures 3-3, 3-4 and 3-5).  These results are 
consistent with trends observed by Boltana et al., (2014) for IL-1β expression in gilthead 
seabream head kidney where IL-1β peaks at 6h and begins to fall by 12h post V. anguillarum 
LPS injection.  However, in isolated head kidney leukocytes exposed to LPS or flagella the 
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expression of IL-1β has been shown to increase through 12h post-stimulation and expression 
does not appear to return to basal levels (Chettri et al., 2011).  Perhaps the different expression 
patterns observed when comparing the whole organ expression levels to isolated leukocyte 
expression is a result of limitations imposed by looking at a group of cells that no longer have all 
the necessary machinery or cell types to produce all the signals required to regulate the immune 
response as the whole organ would.  This could be an example of a system that lacks IL-1β 
antagonist genes like IL-1F or pro-inflammatory regulatory genes like IL-10.  Although these 
important regulators of IL-1β were not investigated given that the cells used by Chettri et al., 
(2011) are a population of all leukocytes isolated from the kidney it is likely that cells able to 
express IL-1F and IL-10 are part of the leukocyte population.  Thus, the difference in expression 
patterns observed may in fact be the result of macrophage and leukocyte migration from the head 
kidney to the spleen, a secondary lymphoid organ, or other sites within the fish, leading to fewer 
cells expressing the IL-1β gene in the head kidney which is observed as a reduction in IL-1β 
gene expression.  While, direct comparison of the rainbow trout and gilthead seabream IL-1β 
gene expression patterns is somewhat challenging given the time points selected for analysis by 
Boltana et al., (2014)  were 3h, 6h, 12h and 24h and the time points investigated here were 4h, 8h 
and 24h, and here EF1α rather than 18s was used as a reference gene, it appears that the 
expression of the IL-1β gene in rainbow trout head kidney from Vibrogen 2 vaccinated fish 
peaks earlier with a higher expression level than in gilthead seabream injected with V. 
anguillarum LPS (Figures 3-3 and 3-4).  While this difference may be attributed to variation in 
species, dose, or the fact that the LPS injection may lack other important bacterial components it 
may also reflect the ability of additional bacterin components to stimulate a strong response.   
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The results for IFNγ gene expression also appear to follow the expected trend and this gene 
is significantly up-regulated at 24h, but not 4h or 8h post-vaccination, however, at 24h one saline 
injected fish also up-regulated IFNγ gene expression at a level consistent with vaccinated fish 
(Figures 3-3 and 3-4).  In general, the results for IFNγ are somewhat inconsistent and it appears 
that fish-to-fish variability may mask significant results particularly at 8h where control fish 
expression levels mix with Vibrogen 2 vaccinated fish levels (Figures 3-3 and 3-5).  
Furthermore, at 4h it appears that two of three control fish have higher IFNγ gene expression 
than either saline injected or vaccinated fish (Figure 3-3).  Despite the challenges this fish-to-fish 
variance creates for understanding IFNγ expression it also suggests that the saline injected fish 
up-regulating the IFNγ gene expression at 24h is likely a fish that was up-regulating IFNγ for 
unknown reasons rather than due to the saline injection, and the well-defined grouping of 
vaccinated fish at 24h suggests that this is a reliable result despite the inconsistencies observed 
for this gene overall (Figures 3-3, 3-4 and 3-5).  Furthermore, in the investigation conducted by 
Chettri et al., (2011) IFNγ gene expression in head kidney leukocytes was not significantly 
altered by stimulation with either LPS or flagellin at 1h, 4h or 12h.  Since this study did not 
extend to investigate the expression of the IFNγ gene at 24h it is not possible to compare this 
result, however, the results of earlier time points appear to be consistent with the results 
presented here.  Notably, just as variability in IFNγ gene expression was observed in this study, 
the IFNγ gene expression in response to different concentrations of LPS or flagellin also 
appeared to be variable, and did not seem to follow an expected pattern where expression 
increased or decreased with volume of stimulant added (Figures 3-3 and 3-4) (Chettri et al., 
2011).  It is possible that the variability observed for IFNγ gene expression at the earlier time 
points reflects low gene copy number in the original sample which lead to a variation in copy 
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number between each pipetted volume, and this in turn lead to variability of the qPCR results 
due to the limitations imposed by sample preparation and the nature of the sample itself (Klein, 
2002).  Additionally, if the study of Chettri et al., (2011) extended past 12h it is possible that by 
24h IFNγ gene expression may have been significantly up-regulated in head kidney leukocytes in 
response to LPS and/or flagellin as was observed here in response to Vibrogen 2.  
While the results for IL-1β and IFNγ appear to follow the expected expression trends in 
head kidney after vaccination with Vibrogen 2, in contrast to the expected up-regulation of MH 
class II associated S25-7, the results indicate that the expression of this gene is not significantly 
altered in head kidney post-vaccination (Figures 3-3 and 3-4).  In fact, although not statistically 
significant it appears that the expression of S25-7 in rainbow trout head kidney is treading 
towards down-regulation at 24h post-vaccination (Figures 3-3, 3-4 and 3-5).  Given that 
significant up-regulation of the IFNγ gene is not observed until 24h post-vaccination it is 
possible that up-regulation of the S25-7 gene occurs at a later time point such as 48h or 72h, 
however, a previous study of S25-7 transcript levels in head kidney following stimulation of 
rainbow trout with phorbol myristate acetate (PMA), a stimulator of protein kinase C that 
involves activation of B cells and T cells, also showed that at 24h post-treatment down-
regulation of the S25-7 gene occurs, and at later time points significant down-regulation of the 
gene is observed (Christie, 2007).   Although it is possible that up-regulation of the S25-7 gene 
may occur after the final 24h time point studied here, this result may in fact, be further evidence 
that head kidney macrophages, and other activated antigen presenting cells, migrate out of the 
head kidney, to other sites where they continue the necessary inflammatory and/or adaptive 
response.  Alternatively, other invariant chains reported in rainbow trout, either 14-1, INVX or 
both, may be up-regulated rather than S25-7, in rainbow trout following vaccination with 
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Vibrogen 2 (Fujiki et al., 2003).  Another possibility is that MH class II in fish may not require 
invariant chain once an immune response is initiated.  
Despite the downward trend of S25-7 expression, TAP1 gene expression is significantly up-
regulated in response to Vibrogen 2 at 24h post-vaccination (Figure 3-4).   Not only is this result 
unexpected because MH class I is thought to be responsible for presenting endogenous antigens 
rather than exogenous antigens, it is also unclear why TAP1 would be up-regulated in rainbow 
trout head kidney following Vibrogen 2 vaccination, while S25-7 gene expression is not 
significantly changed and appears to be treading towards down-regulation (Figure 3-3, Figure 3-
4 and Figure 3-5) (Magnadottir, 2010; Martin et al., 2007).  Nonetheless, these results are 
consistent with the work of Acosta, Lockhart, Gahlawat, Real, & Ellis, (2004), who 
demonstrated that vaccination of Atlantic salmon with a V. anguillarum-V. ordalii bacterin, as 
well as, injection with either V. anguillarum LPS or DNA leads to up-regulation of Mx, a gene 
typically associated with anti-viral activity and thus MH class I presentation (Martin et al., 2007; 
Verhelst, Hulpiau, & Saelens, 2013).  However, these results are contrary to other studies that 
have shown that neither type II interferons nor LPS up-regulate Mx protein in fish (Verhelst et 
al., 2013).  Additionally, if the observed down regulation of S25-7 expression is related to fewer 
antigen presenting cells in the head kidney due to migration of cells out of this organ, the 
dichotomy observed between S25-7 and TAP1 gene expression in rainbow trout head kidney, 
may suggest that different cells are up-regulating the MH class I pathway than are up-regulating 
the MH class II pathway (Figures 3-3, 3-4 and 3-5).  Furthermore, these results may provide 
evidence that teleosts up-regulate MH class I in response to both endogenous and exogenous 
antigens and may suggest MH class II has limited function in comparison to MH class I in fish.  
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Perhaps this is the reason cod have eliminated MH class II machinery in favour of expanding the 
MH class I repertoire (Grimholt, 2016; Star et al., 2011) .   
Overall, these results show IL-1β gene expression is significantly up-regulated in 
comparison to IFNγ, S25-7, and TAP1 at 4h in fish vaccinated with Vibrogen 2 and the 
expression levels of the IFNγ, S25-7 and TAP1 genes are comparable across all time points 
studied (Figure 3-6).  While it appears that the Vibrogen 2 vaccine has a dramatic effect on the 
expression of IL-1β the effect on downstream gene expression, although significant when 
compared to control cells for IFNγ and TAP1, is far less remarkable (Figures 3-4, 3-5 and 3-6).  
This combined with the downward trend of S25-7 gene expression may suggest that the vaccine 
is preferentially driving a pro-inflammatory response and inhibiting the MH class II pathway, or 
perhaps expression of IFNγ, S25-7 and TAP1 may increase at later time points (Figures 3-4 and 
3-5).  Additionally, it is possible that either 14-1 or INVX are involved in MH class II 
presentation or that fish regulate MH class II independent of the invariant chain.  Nevertheless, 
the results presented here provide strong evidence for two alternatives: activated antigen 
presenting cells involved in the MH class II pathway are migrating out of the head kidney and/or 
MH class I is responsible for adaptive immune function and responds to both endogenous and 
exogenous antigen in rainbow trout.  If MH class I in fish, is in fact more heavily involved in 
antigen presentation it may be wise to tailor vaccines for use in aquaculture to stimulate this 
pathway along with the MH class II pathway, or perhaps instead of the MH class II pathway 
altogether.  However more data is necessary to determine which option is most effective for the 
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4.1  General Discussion 
The aims of this work were to: Develop an understanding of the immune response 
triggered by Vibrogen 2; Determine the immunological response type driven by vaccination with 
Vibrogen 2 and; Elucidate the regulation of mRNA at the interface between innate and adaptive 
immunity in rainbow trout.  By investigating four genes, that in mammals play a fundamental 
role in the development of inflammation and/or long-term immunity, this study set out to map 
the changes in mRNA transcript levels of two cytokines; IL-1β and IFNγ and the MH class II 
associated invariant chain, S25-7, as well as, the MH class I associated transporter protein, 
TAP1, in the first 24h post-stimulation.  Two studies; an in vitro study using RTS11 
macrophage-like cells, and an in vivo study focused on the head kidney, were carried out and 
results from these two studies notably differ for IL-1β, IFNγ and S25-7 but not TAP1.   
In both RTS11 and head kidney the IL-1β mRNA transcript is up-regulated however, 
transient expression of this gene is observed in head kidney but not RTS11 cells and while IFNγ 
gene expression remains unchanged, at 4h, 8h and 24h, in RTS11 cells following stimulation 
with Vibrogen 2, expression of this gene in head kidney is up-regulated at 24h post-vaccination 
(Figures 2-3 and 3-4).  In light of previous study results where, isolated head kidney leukocytes 
were shown to have similar IL-1β gene expression trends to those observed in RTS11 cells, and a 
second study where similar expression patterns for IL-1β in head kidney was demonstrated in 
gilthead seabream following injection with V. anguillarum LPS, it is possible the expression 
patterns for the IL-1β gene differ between RTS11 cells and head kidney following stimulation 
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with Vibrogen 2 because RTS11 cells are either unable to migrate or because the cell line lacks 
the variety of necessary cells and/or machinery to regulate the response in the same manner a 
fish with a complete set of arsenal can (Boltana et al., 2014; Chettri et al., 2011).  This may also 
support the lack of change observed for IFNγ gene expression in RTS11 cells as well, however 
the up-regulation of S25-7 and TAP1 in RTS11 may suggest that IFNγ protein is present 
therefore, it is possible the time point that IFNγ was up-regulated in RTS11 cells was not 
sampled or that an initial up-regulation of the gene was not necessary to produce the appropriate 
levels of IFNγ protein (Martin et al., 2007).   
The work of Roher, Callol, Planas, Goetz, & Mackenzie, (2011) who demonstrated that 
macrophages isolated from LPS-exposed rainbow trout head kidney, secrete TNFα as early as 
30min post-stimulation while gene expression is not detected until 3h post-stimulation supports 
the possibility that IFNγ mRNA transcript may be up-regulated in RTS11 following Vibrogen 2 
stimulation later than 24h while stored IFNγ is able to initiate the adaptive immune response.  
However, recent work in zebrafish has shown that there is a significant positive correlation 
between the regulation of IFNγ mRNA transcript and IFNγ protein expression following 
stimulation with phytohaemagglutanin (PHA), a mitogenic plant lectin (Yoon et al., 2016).  
Therefore, it is increasingly likely that the time point at which IFNγ gene expression was up-
regulated is not captured here and although the work of Yoon et al., (2016) indicates that at 4h 
both IFNγ protein and mRNA transcript reach peak levels it is possible that in the study 
presented here, IFNγ mRNA transcript in RTS11 cells stimulated with Vibrogen 2 peaked prior 
to 4h, or was delayed and peaked at a later time that was not described here.  Since significant 
up-regulation of IFNγ was not observed until 24h post-vaccination in rainbow trout vaccinated 
with Vibrogen 2, it is possible that IFNγ mRNA transcript levels peaked between 8h and 24h or 
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after 24h in head kidney (Figure 3-4).  However, the rapid and strong up-regulation of IL-1β at 
4h in RTS11 cells, reached expression levels well above those documented at 4h in vivo 
therefore, IFNγ gene expression is more likely to have peaked prior to 4h in RTS11 cells 
(Figures 2-2 and 3-3).  If IFNγ is up-regulated earlier in vitro than in vivo in these studies it may 
explain the reason S25-7 up-regulation was observed in RTS11 cells but not head kidney, and 
this may also support the higher levels of TAP1 mRNA transcript in vitro versus in vivo (Figures 
2-2 and 3-1).  The notion that IFNγ gene expression was up-regulated at an alternate time point is 
further supported by the observed dose dependent expression of IL-1β, S25-7 and TAP1 in 
RTS11 when gene expression in cells stimulated with 1 in 100 Vibrogen 2 is compared to 
expression in cells stimulated with 1 in 500 Vibrogen 2 (Figures 2-2, 2-3 and 2-4).   
 S25-7 mRNA transcripts in RTS11 cells are significantly up-regulated beginning at 8h 
for 1 in 100 Vibrogen 2 stimulated cells and at 24h for both 1 in 100 and 1 in 500 Vibrogen 2 
stimulated cells however, in rainbow trout head kidney no significant changes in expression are 
observed and at 24h it appears that gene expression for this gene is beginning to trend down 
(Figures 2-3 and 3-4).  The results of this in vivo study are consistent with previous results 
obtained by Christie, (2007) that demonstrated S25-7 gene expression begins to trend down and 
is significantly down-regulated at later time points in response to PMA.   However, in this same 
work Christie, (2007) also observed no significant changes in S25-7 gene expression in RTS11 
cells.  The results obtained in RTS11 cells following stimulation with Vibrogen 2 may differ 
from those obtained by Christie, (2007) because Vibrogen 2 contains natural pathogen 
components and the vaccine may have additives that enhance the immunological response.  It is 
also possible that dosing may play a role in the level of expression and perhaps RTS11 cells 
exposed to a higher concentration of PMA may up-regulate S25-7.  Additionally, the earlier 
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work of Christie, (2007), involved RT-PCR followed by densitometry analysis while RT-qPCR 
was used in the current study which may have increased sensitivity for detection.  Thus, it is 
expected that in RTS11, S25-7 mRNA transcript levels would continue to increase past 24h post-
stimulation with Vibrogen 2, while the results of the in vivo study presented here demonstrate 
down-regulation of S25-7 mRNA transcript levels in rainbow trout head kidney (Figures 2-3 and 
3-4).  Since two additional invariant chains have been identified in rainbow trout, 14-1 and 
INVX, it is possible that while S25-7 is down regulated either 14-1, INVX or both are up 
regulated or that MH class II is expressed independent of increased invariant chain gene 
expression (Fujiki et al., 2003).   
Another possibility is that S25-7 mRNA transcript levels in head kidney are down 
regulated as rainbow trout turn off the MH class II pathway in favour of an MH class I response 
either systemically or in the head kidney.  One reason rainbow trout may choose to down 
regulate the immune response in the head kidney is to protect this important hematopoietic tissue 
from damage and it has been demonstrated by high-throughput RNA-sequencing (RNA-seq) that 
during the early response of zebrafish immunized with a live-attenuated Edwardsiella tarda 
vaccine MH class I associated genes are up-regulated while MH class II associated genes are 
down regulated in the liver, an organ thought to have little or no involvement in the immune 
response (Bystrom et al., 2008; Christie, 2007; Soulliere & Dixon, 2017; Yang et al., 2012).  
Additionally, Christie, (2007) demonstrated that, in response to PMA, the expression of S25-7 
mRNA transcript remains unchanged in a panel of rainbow trout tissues including liver, spleen 
and gill, as well as, in PBLs, while it is down-regulated in head kidney suggesting that down-
regulation of S25-7 may in fact be tissue specific. This along with the results presented in 
zebrafish may suggest that either species, pathogen or both play an important role in the 
89 
 
regulation of the MH class I and MH class II pathways in fish (Yang et al., 2012).  Further 
evidence of this is presented in the in vitro study described here where RTS11 cells, a population 
of cells derived from rainbow trout spleen, are up-regulating S25-7, suggesting rainbow trout 
may shut down the MH class II pathway in head kidney but up-regulate this antigen presentation 
pathway in a secondary immune organ in response to Vibrogen 2.   However, the results from the 
in vitro and in vivo studies when considered together also provide evidence that Vibrogen 2 
activates antigen presenting cells, such as macrophages, and this leads to activation of the MH 
class II antigen presentation pathway which initiates an immune response that requires the 
activated cells to migrate from the head kidney (Figures 2-3 and 3-4).  Furthermore, evidence of 
macrophage migration in response to i.p. injection of a V. anguillarum bacterin has been 
documented in rainbow trout.  In a previous study it was demonstrated that at 1h post-
vaccination a V. anguillarum bacterin accumulates in the kidney and spleen and then begins to 
spread throughout the fish and is found in additional tissues including the mesenteries of the 
gastrointestinal (g.i.) tract and air bladder (Nelson, Rohovec, & Fryer, 1984).  This study further 
demonstrated macrophages that had phagocytosed bacterin persisted throughout the body until 
day 7 when they localized in the spleen, kidney, g.i. tract lamellae and mesenteries, gill arches 
and air bladder however, at day 14 the bacterin was cleared from all sites except the spleen and 
kidney where it persisted and remained present at trial termination on day 28 (Nelson et al., 
1984). 
In both RTS11 cells and rainbow trout head kidney TAP1 mRNA transcript levels are 
significantly up-regulated (Figures 2-3 and 3-4).  This is unexpected and it is unclear why the 
MH class I pathway would be up-regulated in response to Vibrogen 2.  Evidence in mammals 
supporting cross-presentation pathways in macrophages and DCs exists however it suggests that 
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TAP independent non-classical MHC class I HLA-F associated with MHC class I open 
conformers is involved (Basta & Alatery, 2007; Cruz et al., 2017; Goodridge et al., 2013; 
Grimholt, 2016).  It is possible that in salmonids both MH class I and MH class II are up-
regulated and/or TAP1 dependent MH class I is responsible for presentation of both endogenous 
and exogenous antigen, which may provide explanation for the loss of MH class II machinery in 
cod (Grimholt, 2016; Star et al., 2011).  However, the in vivo results presented here indicate 
TAP1 gene expression is up-regulated at 24h post-vaccination while S25-7 transcript levels trend 
down at 24h post-vaccination (Figures 2-4 and 3-5).  If S25-7 mRNA transcript is down 
regulated because activated antigen presenting cells are migrating away from the head kidney as 
was suggested above, it appears that TAP1 mRNA transcripts are regulated in different cells than 
S25-7 mRNA transcripts.  This suggests that expression of the MH class I and the MH class II 
pathway may not be occurring simultaneously in the same cell.  Since the RTS11 cell line is a 
macrophage-like cell line the in vivo and in vitro study results together may provide evidence 
that at minimum two different macrophage cell population exist in rainbow trout.  Therefore, 
rainbow trout vaccinated with Vibrogen 2 may activate two distinct macrophage populations, 
and one is a non-migratory population responsible for MH class I presentation while the other is 
a migratory population responsible for MH class II presentation.  However, this may also be 
evidence in fish of the characteristic plasticity of mammalian macrophages, as well as, the 
presence of two macrophage populations, where one is responsible for the inflammatory 
response and is classically activated (M1) leading to up-regulation of the MH class II pathway, 
while the second is either non-classically activated by, a cytokine such as IL-4 (M2a) or an 
immune complex and the TLR ligand LPS (M2b) leading to MH class I rather than MH class II 
up-regulation, or a third possibility is that IL-10 activates a population of resolution-phase 
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regulatory macrophages (M2c) that are responsible for establishing tissue equilibrium following 
an inflammatory event and these macrophages up-regulate MH class I antigen presentation to 
ensure that any compromised cell is eliminated (Bystrom et al., 2008; Castro & Tafalla, 2015; 
Edholm, Rhoo, & Robert, 2017; Hodgkinson et al., 2015; Sever, Vo, Bols, et al., 2014).  
Overall, the results of the in vitro and in vivo studies when considered collectively show that 
the immune response initiated by the Vibrogen 2 vaccine leads to classical activation of 
macrophages that up-regulate MH class II and may migrate out of the head kidney.  The vaccine 
also appears to lead to up-regulation of TAP1 dependent MH class I in cells.  It is possible that 
cells expressing MH class II are presenting antigen leading to activation of the pathway 
necessary for antibody production while cells up-regulating MH class I are prepared for but do 
not present antigen.  On the other hand, MH class I may also present antigen and thus aid in 
eliminating cells that may have been damaged or compromised either by the inflammatory 
response or the invading pathogen.   
4.2  Challenges and Future Directions 
While the results of this work provide a strong foundation for understanding the immune 
response triggered in rainbow trout in response to Vibrogen 2 and vaccination in general, as well 
as, Gram negative bacteria such as, V. anguillarum and V. ordalii, several challenges 
encountered during data collection and suggestions for future studies are outlined below.  First, 
the work presented here was produced using previously published primers for IL-1β, IFNγ and 
TAP1 however, a new primer set was designed for S25-7 (Chettri et al., 2011; Martin et al., 
2007).  While a blast search was conducted to ensure product specificity for the S25-7 primers 
and a small subset of samples obtained during quantification by qPCR for all four genes were run 
on an agarose gel and compared to a 100 base pair (bp) ladder to confirm product size, due to 
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time constraints the products were not sent for sequencing.  Thus, future work with the S25-7 
primers should include obtaining confirmation of the product sequence.  Additionally, melt 
curves were generated for each 96-well plate run on the Roche LightCycler 480 and in most 
cases one peak per well was observed however, some double peaks did occur.  These anomalies 
appeared to occur intermittently and were not reproducible either within triplicates or between 
repeat plates.  The limited time available for optimization of the qPCR protocol used here may 
contribute to this issue therefore, the double peaks may be eliminated by tweaking the developed 
protocol.  However, given the intermittent nature of this issue it is proposed that the observed 
double peak may have been the result of duplicate alleles, multiple isoforms, splice variants or 
were the result of incomplete splicing events that generated mRNA in low copy number.  It is 
also possible that there was low level gDNA contamination in some samples despite including 
two gDNA removal steps including both column technology and enzymatic elimination.  To 
ensure that sample wells with double peaks were not altering the final crossing point (Cp) value 
the results were carefully considered and the Cp values from double peak wells were compared 
to single peak wells for the same sample.  It was determined that the Cp values between double 
peak and single peak wells were consistent however, in the future determining the sequence of 
the larger bands may be useful.  Second, the nature of working with living organisms such as 
fish, lends to increased variability and reduced sample size.  Here, fish-to-fish variability was 
observed and was most pronounced in the IFNγ results.  Additionally, the sample size at each 
time point for each treatment was three, the smallest sample size that is recommend for statistical 
analysis.  To add strength to the data presented here a second trial was conducted in the same 
manner as the first trial however time constraints did not permit analysis of these samples.  
Therefore, data for this second set of samples is not included in this work and a complete set of 
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samples ready for processing exists that can be included in future analysis and would provide a 
set of data for comparison to the results presented above.  Third, the number of time points 
assessed here was limited to 4h, 8h and 24h as the in vitro study involved only these time points.  
However, during the in vivo study samples were collected at additional time points:1h, 12h and 
48h.  Therefore, quantifying the mRNA transcript levels of IL-1β, IFNγ, S25-7 and TAP1 at 
these additional time points may provide additional data relevant to the immunological pathways 
activated by Vibrogen 2.  Additionally, given the results presented here suggest that IFNγ up-
regulation in RTS11 may occur prior to 4h future work should include a second RTS11 trail 
where cells are collected at 1h, 2h and 3h.  It would also be beneficial to extend the RTS11 trial 
and collect 12h, 48h and 72h samples for better assessment of S25-7 and TAP1 expression.  In 
fact, extending the trial in both RTS11 and rainbow trout to include samples up to two weeks 
post-stimulation may provide data relevant to the innate/adaptive immune interface in fish given 
macrophage migration may persist throughout the first 14 days post-vaccination (Nelson et al., 
1984).  Four, during the in vivo trial not only was head kidney tissue collected but the spleen of 
each fish was sampled, however, the limited time available for data collection did not permit 
analysis of this tissue.  Given that  Nelson et al., (1984) demonstrated macrophages that 
phagocytosed V. anguillarum bacterin localized to rainbow trout kidney and spleen at 1h, 
persisted in these organs during widespread macrophage distribution then re-localized to the 
kidney and spleen at day 14 post-vaccination, and considering the results obtained here for S25-7 
mRNA transcript regulation in rainbow trout head kidney and in RTS11 cells, a macrophage-like 
cell line derived from rainbow trout spleen, investigating the S25-7 transcript levels in rainbow 
trout spleen following Vibrogen 2 vaccination may prove valuable.  Further, in addition to an in 
vitro study in RTS11 cells a second in vitro study in RTgutGC cells, a rainbow trout gut 
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epithelial cell line, was carried out, however, again the limits imposed by time resulted in 
exclusion of these samples from this work.  Therefore, future work may also include an 
investigation of innate and adaptive immune gene expression in response to Vibrogen 2 in 
RTgutGC and this could be coupled with an investigation from in vivo gut samples that were 
collected by another investigator during the rainbow trout trial.  Since the gut is thought to be 
one of the main entry points for V. anguillarum and V. ordalii understanding the immunological 
pathways induced in this organ by the Vibrogen 2 vaccine may provide important data leading to 
a better understanding of the defence mechanisms rainbow trout utilize to combat infection 
and/or develop long term immunity to the bacteria responsible for vibriosis (Austin & Austin, 
2016b).  Five, since the Vibrogen 2 vaccine is a proprietary product it is difficult to assess the 
exact components stimulating the observed immune response and previous studies with V. 
anguillarum preparations and/or components is limited.  Therefore, future studies should attempt 
to vaccinate fish with purified formalin-killed bacteria preparations rather than a prepared 
bacterin and investigators should attempt to assess the response triggered by the different 
bacterial components of V. anguillarum and V. ordalii such as the flagellin and LPS alone as 
well as in multiple combinations to determine the most potent components for immune 
stimulation and future vaccine development.  Additional, considerations for future studies 
include: Processing in vivo trial samples collected from Poly I:C stimulated fish to compare the 
early immune response of rainbow trout to bacterial versus viral pathogens; Investigating the 
expression of additional genes that may be involved at the innate/adaptive immune interface such 
as 14-1, INVX, IL-1F and IL-10 to expand the understanding of immune pathway regulation in 
fish; Optimizing the Vibrogen 2 dilution used in vitro to more closely mimic the dose used in i.p. 
vaccination: Conducting studies with additional rainbow trout cell lines such at RTgill-W1, a 
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rainbow trout gill cell line matched to the corresponding rainbow trout tissue to increase 
understanding of the systemic immune response in fish and; Expanding the investigation of the 
innate/adaptive immune interface gene regulation to include other salmonid species, as well as, 
other teleosts such as, cod, to better understand the evolutionary history of immunity as well as 
the adaptive immune response of teleost fish.   
Finally, perhaps the most important future studies will focus of an examination of the 
protein expression patterns of IL-1β, IFNγ, S25-7 and TAP1 along with other cytokines such as 
TNFα, IL-1F and IL-10 and other MH associated proteins such as INVX, 14-1 and tapasin that 
may be involved in regulating the transition from the innate pro-inflammatory response to the 
antigen presentation pathways of the adaptive immune response in fish.  Additionally, it will be 
important for future studies to follow the adaptive immune response through to the up-regulation 
of MH class I and MH class II protein itself.  Over the years, information about these proteins in 
fish has trickled in however, with antibodies that recognize these important immune proteins 
from rainbow trout and other salmonid species at various stages of development it will not be 
long before studies that permit quantification of fish immune proteins will be more easily 
accessible (Christie, 2007; Kales, 2006; Roher et al., 2011; Sever, 2014; Yoon et al., 2016).  In 
fact, a small repertoire of antibodies for a handful of immune relevant rainbow trout protein 
already exist and Christie, (2007) produced antibodies against rainbow trout invariant chain, 
S25-7 and INVX while both  Kales, (2006) and Sever, (2014) worked with antibodies against 
MH class I proteins.  Furthermore, as part of the work conducted for the studies presented here 
IL-1β, IFNγ and TNFα antibodies were produced and validated.  That is, antibodies were titred 
by enzyme linked immunosorbent assay (ELISA) and reactivity and specificity to recombinant 
protein was shown by western blot for each antibody.  Development of quantitative sandwich 
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ELISAs and enzyme linked immunosorbent spot assays (ELISpot) for each of these proteins was 
also initiated however, optimization of these assays proved challenging and due to time 
constraints, the developmental work has been passed on to another investigator for further 
optimization.  
4.3  Conclusions 
In chapter two, results from an in vitro investigation with rainbow trout macrophage-like 
cells (RTS11) indicate that Vibrogen 2 activates rainbow trout macrophages and this activation 
results in a continuous increase in IL-1β gene expression.  While significant up-regulation of 
IFNγ is not observed it appears a shift occurs and the adaptive immune system is activated.  Not 
only is the MH class II associated invariant chain gene S25-7 up-regulated suggesting initiation 
of the pathway involved in antibody production but TAP1, the MH class I associated transporter 
protein is also up-regulated by Vibrogen 2 in RTS11 cells.  The up-regulation of TAP1 in 
rainbow trout macrophages may suggest that the MH class I pathway in teleost fish is involved in 
cross-presentation and is responsible for responding to both endogenous and exogenous antigens, 
or that the MH class I associated genes are simply up-regulated in preparation for mounting an 
immune response if necessary. 
In chapter three in vivo results indicate that the IL-1β gene is up-regulated and an 
immune response is initiated via the classical inflammatory pathway.  Despite evidence of 
macrophage activation via the classical pathway the MH class II associated gene S25-7 
expression is not significantly altered and trends down while TAP1, the MH class I associated 
gene is up-regulated.  It appears that classically activated macrophages and antigen presenting 
cells expressing MH class II may be migrating out of the head kidney while a second group of 
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cells expressing MH class I remains in the head kidney.  Thus, the results suggest that the 
Vibrogen 2 vaccine activates at minimum two separate and distinct cell populations.  
Together the results of chapter two and chapter three show that the Vibrogen 2 vaccine 
initiates an immune response via the pro-inflammatory pathway and may suggest that alternate 
activation pathways are triggered.  These results also indicate that the immune response is 
progressing towards an adaptive response including antibody production via the MH class II 
pathway in classically activated macrophage cells while cells expressing MH class I may be 
preparing for antigen presentation if necessary; may be involved in homeostasis or may be 
preparing for antigen presentation if endogenous antigens are produced.  Additionally, the results 
may support macrophage plasticity in teleost fish, as well as TAP1 dependent cross-presentation 
in salmonids.  Furthermore, the results indicate that the apparent success of Vibrogen 2 in 
aquaculture may be related to the ability of the vaccine to activate the adaptive immune response 
via the pro-inflammatory pathway.  This response may be enhanced by activation of different 
macrophage populations and/or the ability to activate both MH class II and MH class I antigen 
presentation.  Thus, it may be important to consider both MH class I and MH class II activation 
when developing vaccines for use in aquaculture and taking advantage of cross-presentation may 
allow for the development of vaccines to additional aquatic pathogens.  However, another 
consideration for the development of more effective fish vaccines may be shifting the response 
triggered to favour either MH class II presentation or MH class I presentation rather than 
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Figure A-1: Average number of RTS11 cells at 72h.  Average RTS11 cell counts obtained 
using a Millipore Scepter Cell Counter in control wells versus wells stimulated with 1 in 100 
Vibrogen 2 dilutions 72h post-stimulation to determine if stimulation significantly increases cell 
number.  Analysis by two-way ANOVA followed by Tukey’s multiple comparisons test show no 
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Figure B-1: Average weight and length of rainbow trout.  Average size of control rainbow 
trout versus saline injected and Vibrogen 2 vaccinated rainbow trout obtained using a top loading 
balance and measuring tape at time of sampling to determine if A) weight or B) length is 
significantly different between groups or across time points. Analysis by two-way ANOVA 
followed by Tukey’s multiple comparisons test indicates that no significant differences exist.  
Results are shown as mean ± SEM, n=3.  
